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Abstract
This study estimated the course of health-related quality of life (HRQL) over 8 years among
children newly diagnosed with epilepsy. Levels of HRQL in children newly diagnosed with
epilepsy were assessed over 8 years and compared to levels reported for peers in the general
population. Data came from the Health-Related Quality of Life in Children with Epilepsy
Study, a multi-center prospective study of children in Canada with epilepsy. Parents of
children with epilepsy reported their children were comparable to (or better than) their
counterparts in the general population on the majority of individual health concepts 8 years
post diagnosis. On average, fewer family resources, the presence of parental depressive
symptoms, and cognitive problems are significantly associated with worse HRQL over time.
Future research should focus on interventions that target parental depressive symptoms and
family resources to improve the HRQL of individuals with childhood-onset epilepsy.
Keywords: Childhood epilepsy, health-related quality of life, HRQL, QOL, longitudinal,
child health questionnaire, CHQ, family environment, cognitive comorbidities
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Summary for Lay Audience
Children newly diagnosed with epilepsy have poorer well-being related to their overall
health, also known as, health-related quality of life (HRQL), than their peers in the general
population, but little is known about whether this remains the case in the long-term. Also,
little is known about the factors associated with the course of HRQL for children with
epilepsy in the long-term. The aim of this thesis was to evaluate the course of HRQL over the
long-term in children who have been newly diagnosed with epilepsy. This thesis compared
levels of HRQL in children eight years after a diagnosis of epilepsy to levels of HRQL in
children in the general population. This thesis also identified factors that contribute to change
in HRQL over time in children with epilepsy. Overall, parents of children with epilepsy
reported their children’s HRQL 8 years after diagnosis was similar to the general population.
However, some are experiencing worse or no change in HRQL. Additionally, family
environment, and their children having cognitive problems were associated with HRQL over
time. Taken together, over the long-term children with epilepsy are doing well, however,
some are at risk for poor HRQL. The current results are important in recognizing what
factors other than seizure experience are related to HRQL over time. Understanding that
there is a potential need to identify those at risk for poor HRQL early after diagnosis may
help parents and clinicians to make decisions regarding these children’s health care.
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Chapter 1

1

Introduction

1.1

Thesis Overview

This chapter describes background information regarding important subject areas
explored throughout the thesis including an overview of childhood epilepsy, the
importance of quality of life measurements, and the benefits of longitudinal research.
Chapter Two presents a review of the literature that is specific to the research aims of the
study. Chapter Three includes a description of the purpose of the study and research
objectives. Chapter Four describes the study design and methods used to address the
outlined objectives. Chapter Five presents the results from the analyses. Chapter Six
provides a discussion of the results, conclusions based on the findings and the
implications of the current research.

1.2
1.2.1

Background
Epilepsy Overview

Epilepsy is characterized as a brain disease that includes a predisposition to generating
epileptic seizures. The definition of epilepsy by the International League Against
Epilepsy was revised in 2014 to be that one of three conditions must be met: two
unprovoked seizures less than 24 hours apart; one unprovoked seizure with evidence of
the probability of further seizures; or the diagnosis of an epilepsy syndrome (Fisher et al.,
2014). Seizure types are characterized in order to select appropriate therapies and offer
common language. The classification of seizures was revised in 2017 to include three
types: focal onset, generalized onset and unknown onset (Fisher et al., 2017). Six
groupings of causes of epilepsy have been identified: structural, genetic, infections,
metabolic, immune and unknown (Scheffer et al., 2017).
The World Health Organization (WHO) has estimated that around 50 million people
worldwide have epilepsy, making it one of the most common neurological diseases
(World Health Organization, 2019). Other estimates have suggested that the global
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burden of epilepsy may be even higher with values closer to 65 million people with
epilepsy worldwide (Ngugi, Bottomley, Kleinschmidt, Sander, & Newton, 2010).
Epilepsy affects all ages, sexes, races, income groups and geographical locations (World
Health Organization, 2019). Geographically, the incidence and prevalence of epilepsy
have been reported to be lower in developed countries and highest in rural areas of
underdeveloped countries (Camfield & Camfield, 2015). Furthermore, epilepsy carries
neurological, cognitive, psychological and social consequences (World Health
Organization, 2019). For example, roughly half of people with epilepsy have comorbid
physical or psychiatric conditions. The most common psychiatric comorbidities are
depression and anxiety (Wei & Lee, 2015). Examples of physical comorbidities include
abnormal bone health and polycystic ovary syndrome (Coppola et al., 2009; El-Khayat et
al., 2004). Additionally, having physical and psychiatric comorbidities in people with
epilepsy is associated with poorer health outcomes and decreased quality of life (World
Health Organization, 2019).
Importantly, epilepsy is a treatable condition. Up to 70% of people with epilepsy could
become seizure free with appropriate diagnosis and treatment; however, without access to
care people with epilepsy may remain untreated and face stigma and discrimination
(World Health Organization, 2019).

1.2.2

Childhood-Onset Epilepsy

The incidence of epilepsy is generally higher in the youngest and oldest age groups in the
population (Fiest et al., 2016). The incidence of epilepsy is highest within a child’s first
year of life and often declines to adult levels by around the age of 10 years old (Camfield
& Camfield, 2015). In at least 50% of childhood epilepsy the cause is unknown
(Camfield & Camfield, 2015). From a public health standpoint, the majority of cases of
childhood-onset epilepsy are not currently preventable (Camfield & Camfield, 2007),
however, as 70% of people with epilepsy become seizure free, an emphasis on diagnosis
and treatment over time is essential (World Health Organization, 2019).
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The impact of a diagnosis of epilepsy is associated with direct and indirect costs. Direct
costs include health care costs associated with assessment, diagnosis, and treatment;
whereas, indirect costs include side effects that prevent the person from reaching their
full potential (Chomba, Haworth, Atadzhanov, Mbewe, & Birbeck, 2008; World Health
Organization, 2019). Additionally, direct costs can occur not only due to epilepsy-related
treatment, but also due to comorbidities. Comorbid conditions are common among
children with epilepsy, with population estimates reaching upwards of 70% (Pastor,
Reuben, Kobau, Helmers, & Lukacs, 2015; Sillanpää & Cross, 2009). Comorbidities
among children with epilepsy can be categorized into neurological/cognitive,
psychological/behavioural, and physical (Wei & Lee, 2015). Among all comorbidities,
intellectual disability is the most common in children with epilepsy (30-40%) (Reilly et
al., 2014; Wei & Lee, 2015). Additionally, children with epilepsy have significantly more
sleep problems than the general population (Wei & Lee, 2015). Among
psychiatric/behavioural comorbidities, Autism Spectrum Disorder (ASD) (as high as
32%) (Clarke et al., 2005), Attention Deficit Hyperactivity Disorder (ADHD) (12-39%)
(Reilly, 2011), depressive and anxiety disorders (12-24%) are the most common (Caplan
et al., 2005; Wei & Lee, 2015). Furthermore, physical comorbidities associated with
seizure medication may have a long-term effect on the physical health and quality of life
of children with epilepsy (Wei & Lee, 2015).
The high prevalence of comorbid conditions among children with epilepsy and the
positive prognosis of reduction of seizures in the long term, highlights the need to not
solely focus on seizure-related clinical factors when treating epilepsy. Studying the whole
picture of the child’s health, including comorbid conditions and health-related quality of
life (HRQL), to measure outcomes through childhood and into adulthood is very
important.

1.2.3

Health-Related Quality of Life in Children with Epilepsy

The WHO defines Quality of Life (QOL) as "an individual’s perception of their position
in life in the context of the culture and value systems in which they live and in relation to
their goals, expectations, standards and concerns. QOL is a broad ranging concept that is
affected by the relationship between a person's physical health, psychological state, level
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of independence, social relationships, personal beliefs and their relationship to salient
features of their environment" (WHO, 1995, p. 1405). HRQL is the facet of QOL that is
directly relevant to delivery of health care. Hays and Reeve (2016) defined HRQL as a
focus on how a person assesses their functioning in life and their perceived well-being in
physical, mental and social domains of health. Functioning refers to a person’s ability to
carry out a defined activity while perceived well-being refers to a person’s subjective
feelings. HRQL highlights the importance of connecting well-being and functioning in
daily life to health concerns. Understanding the connection between QOL and health can
in turn influence how health care is delivered.
With respect to the treatment of childhood epilepsy, treatment has shifted from focusing
on management of seizures to incorporating measurements of (HRQL) (Jones, 1998;
Schachter, 2000). Treatment of epilepsy should be considered a multi-faceted process
with an emphasis on community-based care (World Health Organization, 2019).
Ultimately, the goal of treatment is to optimize HRQL (Thurman et al., 2011).
Understanding the course of HRQL for individuals with disease is integral to families and
clinicians. For families, understanding the potential impact of epilepsy on HRQL can aid
in predicting what life may look like for those with epilepsy to aid in planning for the
future. For clinicians, it means identifying children at risk for poor HRQL and working
with families to allocate additional resources aimed at achieving more positive outcomes.
To optimize HRQL, it is important that we have an agreed-upon way to meaningfully
interpret scores derived from HRQL questionnaires. Specifically, we need to know how
large the changes observed in HRQL scores must be to be viewed as meaningful. In the
absence of methods to practically interpret HRQL scores observed in children with
epilepsy such as minimal clinically important difference (MCID), one way to attach
meaning to HRQL scores is to use relative comparisons between children living with
epilepsy and healthy age-matched counterparts in the general population or children
living with other chronic health conditions. To compare across different populations
requires the use of a generic measure of HRQL, as opposed to disease-specific measures.
One such generic measure that has been used in childhood chronic diseases is the Child
Health Questionnaire (CHQ) (Landgraf, Abetz, & Ware, 1996).
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HRQL in children with epilepsy has been described in the HEalth-Related QUality of
Life in children with Epilepsy Study (HERQULES) (Speechley et al., 2012).
HERQULES is a multi-center prospective cohort study of children with new-onset
epilepsy in Canada that measured HRQL at six time points across a 10-year span. A total
of 374 children were included in the sample at baseline. In the first phase of
HERQULES, the course of HRQL in children with epilepsy throughout the first two
years post-diagnosis was described. It was determined that 56% of children with newonset epilepsy experienced either no clinically important improvement (37%) or a
clinically important decline (19%) in the psychosocial health subscale of HRQL over the
first two years since diagnosis. On a physical health subscale, 61% experienced either no
clinically important improvement (43%) or a clinically important decline (18%) over the
first two years (Speechley et al, 2012). Furthermore, it was determined that at diagnosis,
compared to a population-based normative sample from the United States (Landgraf,
Abetz and Ware, 1996), children with newly diagnosed epilepsy had lower HRQL on
most domains measured. Two years later, ratings were more similar to the populationbased normative sample, except for psychosocial health (Speechley et al, 2012). The
second phase of HERQULES extended the window of observation from the 2-year follow
up to 8-10 years later—presenting the opportunity to describe the long-term course of
HRQL. To date the long-term HRQL in this sample has been reported using a diseasespecific measure of HRQL (Puka et al., 2020), but what remains to be assessed is the
long-term course of HRQL, using a generic measure and comparing these outcomes to a
same-aged sample from the general population. Similarly, the long-term follow up
presents the opportunity to assess the baseline factors associated long-term HRQL.

1.2.4

Longitudinal HRQL in Children with Epilepsy

The study of HRQL in children with epilepsy (CWE) is often conducted using crosssectional or short-term cohort studies. Cross-sectional study designs provide snapshots of
patients’ HRQL but do not provide information on the course of HRQL in the long-term.
It has been reported that the ultimate goal of treatment of childhood epilepsy is to
optimize HRQL and understanding what factors are associated with increased HRQL
over the long term is pertinent to the overall picture of the course of epilepsy in children
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(Thurman et al., 2011). Longitudinal research has the potential to offer information to
parents regarding prognosis and the potential course for their child’s HRQL later in life.
Additionally, understanding what factors are associated with positive HRQL, may aid
parents to make informed decisions regarding modifiable attributes of their child’s life
such as their child’s health care or family environment that may benefit their child
throughout the course of their life. The proposed thesis research will extend the
description of the course of HRQL to the long term.
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Chapter 2

2

Literature Review

This chapter provides an overview of health-related quality of life (HRQL), the Child
Health Questionnaire (CHQ), and factors affecting HRQL in children with epilepsy. A
comprehensive search strategy was completed, searching both PubMed and PsycINFO.
Overall, the search included studying HRQL of childhood epilepsy, the Child Health
Questionnaire, and instances where the Child Health Questionnaire was used to evaluate
the outcome associated with childhood epilepsy or other chronic health conditions in
children and adolescents. Studies included for review were limited to those where the age
range of the sample was between 5 and 18 years. In total, 341 unique papers were
identified, extracted, and read. Additional relevant articles were assessed through review
of reference lists.
The first section focuses on the definition and measurement of HRQL (Section 2.1). The
second section draws attention to one specific measure of HRQL, the Child Health
Questionnaire (Section 2.2). The third section focuses on the association between HRQL
(Section 2.3), family environment (Section 2.3.1), parental mood (Section 2.3.2) and the
effect of psychiatric comorbidities (Section 2.3.3) on children with epilepsy. The final
section outlines limitations in the literature to date (Section 2.4).

2.1

What is Health-Related Quality of Life?

HRQL is the facet of QOL that is directly relevant to delivery of health care. Different
definitions of HRQL may focus solely on areas of quality of life that are related to health,
disregarding concepts like the economy and politics (Karimi & Brazier, 2016). Other
definitions, such as those proposed by Hays and Reeve (2016), define HRQL as a focus
on how a person assesses their functioning in life and their perceived well-being in
physical, mental and social domains of health. In this case, functioning refers to a
person’s ability to carry out a defined activity; whereas, perceived well-being would refer
to a person’s subjective feelings. Overall for the context of this thesis, HRQL highlights
the importance of connecting well-being and functioning in daily life to health concerns.
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In other terms, HRQL refers to the impact, both subjective and objective, of impairment
as it relates to a disease, health policy or treatment (Spieth & Harris, 1996). Studying and
evaluating HRQL using a patient’s self-reported experiences can provide a subjective
record that compliments a patient’s diagnosis and prognosis. The coordination between
subjective measurements and objective measurements can impact a patient’s healthcare
decisions. Monitoring and understanding HRQL over time in certain diseases, can lead to
identification of patients at risk for poorer HRQL and predict health outcomes, including
health care costs (Ryan et al., 2016). Understanding the connection between QOL and
health can in turn influence how health care is delivered.

2.1.1

Measuring Health-Related Quality of Life in Children

Measuring HRQL in children involves assessing functioning that is directly affected by
an illness or its treatment. Therefore, it is pertinent to identify what areas of functioning
are being measured and how those areas align with the definition of HRQL. In assessing
areas of functioning, measurements can focus on the multi-dimensionality of HRQL or
alternatively, consider more specific, individual domains of HRQL. Typically, most
descriptions of HRQL refer to four core domains of quality of life: disease state and
physical symptoms, functional status, psychological functioning, and social functioning
(Spieth & Harris, 1996).
In addition to measuring the individual domains or the multi-dimensionality of HRQL, it
is important that researchers have an established method by which to meaningfully
interpret scores derived from HRQL measures. Specifically, we need to know how large
the changes observed in HRQL scores must be to be viewed as meaningful. One way to
attach meaning to HRQL scores is to use relative comparisons between children living
with a certain disease and healthy age-matched counterparts in the general population or
children living with other chronic health conditions. To compare across different
populations requires the use of a generic measure of HRQL, as opposed to a diseasespecific measure (Miller, Palermo, & Grewe, 2003). Additionally, the use of a generic
measure provides information on the relative burden of a certain disease or chronic
condition that cannot be concluded using a disease-specific measure (Asmussen et al.,
2000). A disease-specific measure may be more sensitive in identifying specific illness
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related predictors, however (Miller et al., 2003). The use of disease-specific versus
generic HRQL measures has been investigated in food allergic patients where diseasespecific measures highlighted clinically important impairments and the use of generic
measures was found to be indispensable for comparing between different diseases and
complimenting clinical findings (Flokstra-de Blok et al., 2010). It has been recommended
that when studying HRQL, both generic and specific perspectives be included to
visualize the whole picture and aid patients (Miller et al., 2003).
The measurement of HRQL usually requires patients’ self-report based on their
reflections of their life and overall functioning. HRQL measures are developed and
considered for use based on four aspects: relevant age range, reliability, validity and the
extent to which the measures coincides with the researchers’ definition of HRQL
(Janssens, Gorter, Ketelaar, Kramer, & Holtslag, 2008).
Studying HRQL in children poses certain challenges. For example, often an adult, in
most cases, the parent of the child is required to report on behalf of the child. However,
there are measurements that include versions to be completed by children and versions
completed by parents, such as, the Child Health Questionnaire-Child-Form and CHQParent-Form, versions of the DISABKIDS, versions of the KINDL-R, the KIDSCREEN,
and versions of the PedsQL (Hullmann, Ryan, Ramsey, Chaney, & Mullins, 2011).
Child-report questionnaires often have the option to be administered through a selfadministered questionnaire or an interviewer-administered format. Studies have found
that there are differences between child and parent reports of HRQL (Baca, Vickrey,
Hays, Vassar, & Berg, 2010). It has been established that the perspective of a parent may
be different than their child. To gain the full picture, both perspectives should captured
whenever possible (Baca et al., 2010; Fong et al., 2018) . It should be clearly stated, when
solely the parents’ or children’s report is analyzed. Using a measure that has
demonstrated acceptable levels of validity and reliability is an important consideration is
selecting a measure of a children’s HRQL (Hullmann et al., 2011).
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2.2

The Child Health Questionnaire (CHQ)

A review of all generic HRQL measures for children aged 5-18 identified a total of 14
measures, including, Child Health and Illness Profile Adolescent and Child Edition
(CHIP-AE/CE), Child Health Questionnaire—Child and Parent Forms (CHQCF87/PF50/PF28), DISABKIDS, Functional Status II (FS II)(R), Health Utilities Index
Mark 2 (HUI 2), KIDSCREEN 52/27, KINDL, Pediatric Quality of Life Inventory
(PedsQL), The Netherlands Organization (TNO) Institute of Prevention and Health and
the Leiden University Hospital (TNO-AZL), TNO-AZL Children’s Quality Of Life
(TACQOL), and Youth Quality of Life Instrument—Research Version (YQOL-R)
(Janssens et al., 2008). The measure used for this thesis is one of these, the Child Health
Questionnaire Parent Form-50 (CHQ PF-50) (Landgraf et al., 1996). The CHQ-PF50 is a
50-item, generic, well-validated and reliable measure with strong psychometric properties
(Hullman et al, 2011). The questionnaire is validated for parent-report of HRQL for
children ages 5-18 with various acute and chronic health conditions and from the general
population. Additionally, the CHQ has been studied in diverse populations. Upon
completion, the questionnaire results in two summary scores, psychosocial and physical
health, and fourteen subscale scores (Landgraf et al., 1996). The CHQ allows for a
detailed look at individual domains of HRQL that illuminates individual aspects of
HRQL that are comprised to assist in specially targeting them in an intervention
(Landgraf et al., 1996).

2.2.1

Description of the CHQ Scales

The CHQ-PF50 contains 50-items. The response options for the CHQ are ordinal level
and vary by the item. Each item consists of 4–6 response options. Additionally, each
scale consists of varying numbers of items. Most scales use a recall period of four weeks.
The change in health subscale has a recall period of one year, and both the family
cohesion and general health scales refer to the child’s health “in general”.
Fourteen health concepts are considered in the CHQ. A brief description of each of these
health concepts developed by Landgraf et al. (1996) is provided in Table 2.1.
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Table 2.1: Description of CHQ Health Concepts
Health Concept
Name

Description of Health Concept

Physical
functioning

Measures the presence and extent of physical limitations due to health-related
problems. Self-care, mobility and activities varying in severity of
strenuousness are included. A four-level response continuum that ranges from
“yes, limited a lot” to “no, not limited” is provided.

Role/Social
LimitationsPhysical

Measures the extent of limitation in school-related activities and activities with
friends related to physical health problems. A four-level response continuum
that ranges from “yes, limited a lot” to “no, not limited” is provided.

General Health

Subjective assessment of overall health and illness. Responses to statements of
their child’s past, future and current health, using a five-level continuum from
“definitely true” to “definitely false”, are provided.

Bodily
Pain/Discomfort

This scale is included as an indicator of physical health. Items are designed to
assess both intensity and frequency of general pain and discomfort. The degree
of bodily pain or discomfort is assessed along a six-level response continuum
that ranges from “none” to “very severe”.

Parental ImpactTime

Captures the extent of limitations in personal time experienced by the
respondent, be it parent or guardian, due to the following areas: child’s
physical health, emotional well-being, attention or learning abilities, child’s
ability to get along with others, and general behaviour. A four-level response
continuum that ranges from “yes, limited a lot” to “no, not limited” is
provided.

Parental ImpactEmotional

Captures the amount of distress experienced by the respondent for each of the
following areas: child’s physical health, emotional well-being, attention or
learning abilities, child’s ability to get along with others, and general
behaviour. Responses along a five-level continuum from “none at all” to “a
lot” are provided.

Role/Social
LimitationsEmotional

Designed to measure limitations in the kind, amount and performance of
schoolwork and activities with friends due to emotional difficulties. A fourlevel response continuum that ranges from “yes, limited a lot” to “no, not
limited” is provided.

Role/Social
LimitationsBehavioural

Similar to that of the social limitations-emotional, designed to measure
limitations due to solely behavioural difficulties. A four-level response
continuum that ranges from “yes, limited a lot” to “no, not limited” is
provided.
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Self Esteem

The scale captures satisfaction with school and athletic ability,
looks/appearance, ability to get along with others and family, and life overall.
A five-level response continuum that ranges from “very satisfied” to “very
dissatisfied” is provided.

Mental Health

Measures the frequency of both negative and positive states of mental health.
Frequency is measured using a five-level continuum that ranges from “all of
the time” to “none of the time”.

General
Behaviour

Measures overt behaviour as a component of mental health. The frequency of
behavioural problems and ability to get along with others are measured using a
five-level response continuum that ranges from “very often” to “never. A
global item is also provided that rates the child’s behaviour overall, along a
five-level continuum that ranges from “excellent” to “poor”.

FamilyLimitations in
Activities

Designed to assess the frequency of disruption in “usual” family activities.
Reponses are provided using a five-level response continuum ranging from
“very often” to “never”.

Family-Cohesion

A global family cohesion item is provided, and the respondent is asked to rate
how well his/her family “gets along with one another” using a five-level
continuum that ranges from “excellent” to “poor”.

Change in Health

A global change in health score over the previous year is included along a
five-level response continuum that ranges from “much better now” to “much
worse now”.

In addition to the 14 health concepts in Table 2.1 measured using the CHQ, two
aggregate scores are derived, the psychosocial and physical health summary scores.
Scores are transformed to a 0-100 scale with a mean of 50 and standard deviation of 10
(Landgraf et al., 1996).
When using the CHQ as a tool, studies decide to incorporate all fourteen subscales, some
of the scales, or to focus solely on the summary scores. For example, Bruijn et al., (2009)
presents results from all of the subscales but focuses on differences within mental health,
parental impact time and family cohesion whereas Baildam et al., (2011) included
multiple different questionnaires within their study, but focused solely on the family
activity subscale from the CHQ. Studies may also report all subscale measurements but
focus on the two summary scores for general results (de Wit et al., 2008)
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2.2.2

Psychometric Properties of the CHQ

The CHQ has strong psychometric properties. It is feasible to use. A study of Dutch
school children, showed that <2% of data were missing on the CHQ-PF50, and that the
scale with the most missing items was the single item scale “Family cohesion” (4%)
(Raat, Landgraf, Bonsel, Gemke, & Essink-Bot, 2002).
As for reliability, internal consistency for the CHQ-PF50 has been rated as
good. Cronbach’s alpha coefficient for Dutch schoolchildren was calculated to range
from 0.39–0.96 for an average of 0.72 for the subscales (Raat et al., 2002). Additionally,
Cronbach’s alpha coefficient has been computed for United States schoolchildren (0.660.94), children with ADHD (0.56-0.89), children with epilepsy (0.71-0.94) and children
with juvenile rheumatoid arthritis (0.60-0.90) (Landgraf et al., 1996).
Convergent validity was found to be acceptable, with correlations ranging from 0.21–
0.49 for parallel domains on the CHQ compared to the Health Utilities Index (HUI)
(Hullmann et al., 2011; Raat et al., 2002). Discriminant validity was also found to be
moderate to strong (Hullmann et al., 2011; Raat et al., 2002).

2.2.3

The CHQ as a Generic Measure of HRQL

Using a generic measure makes it possible to directly compare HRQL across chronic
conditions and with normative populations. Normative data make it possible to interpret a
child’s health score, or the average of a group, compared with groups of other children.
To make relevant comparisons, a valid norm from a well-defined representative sample,
that was taken from a population of interest in required. The CHQ-PF50 manual presents
a set of general population normative data from the United States. The norms were
estimated from responses to the National Survey of Functional Health Status (NSFHS), a
1994 cross-sectional survey (Landgraf, Abetz, and Ware, 1996). It is important to note
that another version of the CHQ, the CHQ-PF28, is embedded within the CHQ-PF50 and
is commonly used as a shorter version of the CHQ-PF50 (Houben-van Herten, Bai,
Hafkamp, Landgraf, & Raat, 2015; Vet et al., 2016).
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Since publication of the CHQ and its U.S. normative data, additional populations have
been studied. In 2000, Australian populations norms were published from a
representative sample of parents of school-aged children (Waters, Salmon, Wake,
Hesketh, & Wright, 2000). Additionally, in 2003, a random national sample of Australian
school-aged children was obtained and socioeconomic differences were investigated
(Spurrier, Sawyer, Clark, & Baghurst, 2003). In 2015, a population study in the
Netherlands published normative data from the Dutch population (Houben-van Herten et
al., 2015). Having access to multiple sets of normative data allows for studies to compare
not only within one country but to expand globally. For example, AttentionDeficit/Hyperactivity Disorder (ADHD) has been studied in the Canadian population,
however, without Canadian norms, both U.S. and Australian norms were compared to
compliment results found in Canada (Klassen, Miller, & Fine, 2004).
A generic questionnaire also allows for comparisons between the general population and
a population with a chronic disease. Comparing people with chronic diseases and their
counterparts in the general population provides a method to understand the impact a
chronic disease may have on HRQL in an individual. Additionally, understanding how
those with a chronic disease differ from the general population in particular domains of
HRQL may aid parents and health care practitioners to make informed decisions
regarding a child’s health care. The CHQ has been used across many health conditions to
compare to normative populations. For example, the CHQ assessed differences between
children with cystic fibrosis (Britto et al., 2002), cerebral palsy (Bjornson et al., 2008;
Davis et al., 2009), tooth disease (Burns, Ryan, & Ouvrier, 2010), leukemia (Gordijn et
al., 2013), septic shock (Buysse et al., 2008) and human immunodeficiency virus (HIV)
infected children (Byrne & Honig, 2006). In addition to using published population
normative data, studies also have the opportunity of assembling their own reference
populations and comparing them with their study sample (de Wee et al., 2011).
In addition to normative data from the general population, generic measures provide
benchmarks for clinical conditions. The CHQ provides five clinical condition
benchmarks including, asthma, ADHD, epilepsy, psychiatric disorder, and juvenile
rheumatoid arthritis (Landgraf, Abetz and Ware, 1996). Including clinical condition data
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allows for comparisons not just with the general population and globally, but also within
different chronic conditions.
When a family has a child with a health condition, comparisons can be made between the
HRQL of the child with the condition and another child within the family, used as sibling
controls. Insight into sibling differences can help teams studying health conditions to
provide family-oriented care. Chiou, Jang, Liao, & Yang,. (2010), compared children
who have survived leukemia, their siblings, and aged-matched controls. Providing a
control group within the family attempts to control for characteristics of the family
environment such as family functioning that may be directly associated with HRQL. It
was reported that the HRQL of children with leukemia was worse than their siblings and
other children in the community. It was concluded that, pediatric leukemia survivors
carried a burden on HRQL into their teen years as reflected by worse HRQL than both
types of controls. Findings comparing both within the community and within families
guide the support required by a population (Chiou et al., 2010).

2.2.4

Determining Clinical Relevance of CHQ scores

To determine whether scores derived from self-report questionnaires are clinically
different, a minimal clinically important difference (MCID) is often used. An MCID is
defined as “the smallest difference in score in the domain of interest that patients perceive
to be beneficial and that would mandate, in the absence of troublesome side effects and
excessive costs, a change in the patient’s management”. MCIDs allow for health
practitioners to assign significance to an observed score that includes both a patient’s
perception and their clinical characteristics (Jaeschke, Singer, & Guyatt, 1989). To date, a
minimal clinically important difference has not been established for the CHQ-PF50.
In the absence of an agreed upon MCID for a given measurement, other methods are used
to determine if scores in a sample are indicative of a clinically important difference.
Common distribution-based methods include Standard Error of Measurement (SEM), use
of effect sizes, and standard deviation (Rai, Yazdany, Fortin, & Aviña-Zubieta, 2015).
The SEM estimates the average number of points by which an observed score differs
from the true scores. SEM is estimated by standard deviation of the measure multiplied
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by the square root minus its reliability coefficient (Anastasi & Urbina, 1997). The SEM
criterion has been established for identifying clinically meaningful intra-individual
change in reliable and valid HRQL instruments (Wyrwich, Tierney, & Wolinsky, 1999).
The SEM-based criterion has been used previously in earlier HERQULES analyses to
evaluate scores derived from the CHQ-PF50 (Speechley et al., 2012). Another
distribution method uses standard deviation as a measure of variability interpreting scores
greater than or equal to 0.5 standard deviations as clinically different (Rai et al., 2015). A
similar rule exists for use of effect sizes.

2.2.5

Longitudinal Studies Using the CHQ

Longitudinal studies have the potential to offer information to parents regarding long
term prognosis associated with their child’s epilepsy diagnosis. Extending prospective
studies longitudinally, past one or two years, offers the ability to chart the course of
HRQL in a child’s life into adulthood. Using a relevant, valid and reliable measure, such
as the CHQ repeatedly over time in the same population can begin to answer questions
regarding the course of HRQL.
The CHQ is validated for use of participants aged 5-18 (Landgraf, Abetz, and Ware,
1996). In the case of longitudinal research, participants may surpass the age of 18 and no
longer be within the validated use of the questionnaire. There are various ways to deal
with these challenges. One method is to only consider those below the upper age limit for
data analysis (Hesketh, Wake, & Cameron, 2004). Another option is to use the CHQ for
those at or below 18 years of age and include an adult self-report questionnaire of HRQL
such as the WHOQOL (World Health Organization Quality of Life) for those above the
age of 18 (Zuidema et al., 2018).
Numerous examples of longitudinal studies using the CHQ exist in the literature (Ferro,
Landgraf, & Speechley, 2013; Speechley et al., 2012). For example, Randhawa, Cetto,
Chilvers, Georgalas, & Narula (2011), followed children
undergoing adenotonsillectomies over four years. Measurements were taken pre-surgery
and again at follow up, in the long term. Results concluded that the benefits of surgery
are persistent at 4-year follow-up. Another example using multiple measurements
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includes a study that compared subjects born extremely premature with those born at fullterm. Participants were assessed at both 10 and 18 years of age and developmental
trajectories were developed using scores from the CHQ. Results suggested that a
longitudinal perspective is required when addressing health and well-being questions in
those who are born extremely prematurely (Vederhus et al., 2015). The previous studies
focus on measurements taken at two time points. However, multiple measurements can
be taken across time to form a more descriptive course of HRQL. For example, DeMatteo
et al., (2014), studied HRQL in children after sustaining a brain injury, at three time
points over the span of five years. Including multiple time points allowed for the authors
to discuss changes not only between baseline and five years, but also include the
difference between baseline and eight months post injury (DeMatteo et al., 2014).
Another study measured HRQL in children with physical disabilities at three data points
over 18 months (Law et al., 2014). Results from the study highlighted factors that
predicted changes in HRQL over time and indicated how this knowledge could inform
clinical services and policy developments.

2.2.6

Summary of the Benefits of the CHQ

The CHQ provides a generic measure of HRQL for use with children in the general
population or those experiencing a health condition. The CHQ is a versatile tool that can
be used longitudinally for measuring the course of HRQL over time and to compare
results from a sample with a health condition to age-counterparts in the general
population. Combining the ability to measure over time, identify predictive factors, and
compare to normative populations, the CHQ has the potential to inform parental
decisions, influence health interventions, and potentially provide suggestions for health
policy decisions.

2.3

Health-Related Quality of Life in Children with Epilepsy

Epilepsy is characterized as a brain disease that includes a predisposition to generating
epileptic seizures (Fisher et al., 2014). The treatment of childhood epilepsy has shifted
from focusing on management of seizures to incorporating measurements of HRQL
(Jones, 1998; Schachter, 2000). Research has found that children with epilepsy have
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diminished HRQL compared to healthy children (Bansal, Azad, Gudala, & Dasari, 2017;
Cianchetti et al., 2015). Therefore, in addition to focusing on minimizing seizures, an
emphasis on improving HRQL has been acknowledged as essential (Cianchetti et al.,
2018; Sabaz et al., 2003; Taylor, Jacoby, Baker, & Marson, 2011). Epilepsy has been
shown to impair HRQL in children, but also, within their families, which may not be
related to the severity of the epilepsy itself (Cianchetti et al., 2015). It has been
highlighted that attention to seizure control in a clinical setting will not address the full
range of QOL-related problems within children with epilepsy and their families (Austin,
Smith, Risinger, & McNelis, 1994).
Additionally, comorbidities are common amongst patients with epilepsy and therefore,
treatment of epilepsy should be considered a multi-faceted process with an emphasis on
community-based care (World Health Organization, 2019). Managing comorbidities is
essential throughout all levels of care, including primary, specialist and therapeutic care.
Availability of community-based care allows for all people in need of epilepsy services to
access them and manage comorbidities (World Health Organization, 2019).
The Health-Related Quality of Life in Children with Epilepsy Study (HERQULES)
assessed HRQL in a group of children newly diagnosed with epilepsy and followed them
longitudinally for up to 10 years. Data derived from the CHQ-PF50 determined that, with
regards to psychosocial health, 56% of children with epilepsy in the study experienced
either no clinically important improvement (37%) or a clinically important decline (19%).
On the physical health subscale, 61% experienced either no clinically important
improvement (43%) or a clinically important decline (18%) (Speechley et al., 2012). It
was also determined that at diagnosis, children with newly diagnosed epilepsy have lower
HRQL on most domains measured compared to a population normative sample from the
United States (Speechley et al., 2012). Two years later, ratings were more similar to the
population normative sample, but not for measures of psychosocial health. Additionally,
after controlling for baseline HRQL, cognitive problems, poor family functioning, and
high family demands were risk factors for low HRQL two years later (Speechley et al.,
2012). Within the HERQULES sample, child and family risk factors at diagnosis have
been found to predict HRQL 2 years post-diagnosis which allowed for identification of
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those at risk for lower HRQL soon after diagnosis (Ferro, Landgraf, et al., 2013). Selfreported HRQL has also been found to be directly related to health care costs. Children
with poor, declining HRQL incur higher health care costs compared to those with stable,
high HRQL (Ryan et al., 2016). Research targeting the identification of potentially
modifiable traits is important as it can offer insight into how we might improve HRQL in
children diagnosed with epilepsy. By identifying children at risk for compromised HRQL
soon after diagnosis of epilepsy, an opportunity is presented to target families for health
care resources aimed at improving HRQL (Speechley et al., 2012).
Controlling seizures is an essential factor in treating epilepsy. However, ultimately the
goal of treatment is to optimize HRQL over the long term (Thurman et al., 2011).
Assessing HRQL may offer a way to identify a subset of patients at risk who could
benefit from interventions aimed at improving HRQL.

2.3.1

The Role of Family Environment in determining HRQL of
Children with Epilepsy

When studying children diagnosed with epilepsy, the importance of expanding the focus
beyond epilepsy-related factors has been widely accepted. A variety of aspects of the
family environment may affect HRQL in children diagnosed with epilepsy. A
combination of clinical and family factors have been reported previously from the
HERQULES sample, to be associated with HRQL in children with epilepsy and
understanding these associations has implications for research and healthcare decisions
(Ferro et al., 2014).
Studies have emphasized a range of family factors that play a role in the HRQL of
children with epilepsy. Having fewer family resources has been found to be associated
with diminished HRQL in children with epilepsy (Conway et al., 2016). In addition,
family functioning and family demands were identified as risk factors for HRQL in the
same sample as the current study (Speechley et al., 2012). Additionally, a recent study
assessed the effects of family management styles on children’s HRQL (Im, Cho, & Kim,
2019). Family management styles are defined as a family’s response to a health-related
challenge, in this case, a diagnosis of epilepsy in a child. Family management styles
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incorporate how the family copes, adapts and functions in response to the health-related
challenge. Adopting an easy family management style was determined to be the most
important factor in predicting HRQL of children with epilepsy (Im et al., 2019). An easy
family management style reflects the extent to which a parent perceives the child’s daily
life as ‘normal’ despite having epilepsy (Im et al., 2019). Results that highlight the effect
of family factors on a child’s HRQL call for comprehensive interventions that focus on
the family environment as well as epilepsy factors (Im et al., 2019). Ultimately,
comprehensive interventions that involve children and their families are important in
addressing the non-medical aspects of family experiencing a epilepsy diagnosis (Conway
et al., 2016; Jain, Subendran, Smith, & Widjaja, 2018).

2.3.2

Parental Mood and Mental Health

Parental mood and mental health have been shown to affect parental HRQL as well as
their child’s HRQL. Terms such as caregiver mood, parental coping, emotional impact,
psychosocial health, parental anxiety and depression are commonly used across the
literature to characterize parents’ mood and mental health.
Caregiver mood has been found to be a correlate of caregiver HRQL, actually more
important than the child’s seizure related variables (Jain et al., 2018). In addition to
caregiver mood, mother’s depressive symptoms have been investigated. In the
HERQULES sample, a substantial proportion of mothers of children with epilepsy were
found to be at risk of depression, and that risk remained stable over the long term (Ferro,
Avison, Campbell, & Speechley, 2011; Puka, Ferro, Anderson, & Speechley, 2018). The
family environment, including parental depressive symptoms, at time of diagnosis can
have long term effects on mothers of CWE (Puka, Ferro, et al., 2018). Research supports
that HRQL of CWE is dynamic and understanding the role of parental HRQL on child’s
HRQL and vice versa is pertinent on establishing viable interventions (Puka, Tavares,
Anderson, Ferro, & Speechley, 2018). A bidirectional relationship between child’s
HRQL and parental HRQL has been elucidated and should be considered when studying
HRQL in children with epilepsy (Jain et al., 2018).
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Understanding the HRQL of parent’s with CWE is essential. However, it is also essential
to understand how parents’ mood and mental health may affect their children’s HRQL
and vice versa. Overall, studies have concluded that parental mood and mental health is a
contributing factor to HRQL in CWE (Connolly et al., 2006; Jain et al., 2018;
McLaughlin, Schraegle, Nussbaum, & Titus, 2018; Puka, Ferro, Anderson, & Speechley,
2019; Taylor et al., 2011; Yong, Chengye, & Jiong, 2006). For example, among children
diagnosed with benign rolandic epilepsy, the emotional impact on a parent of a child
experiencing epilepsy was the major factor in determining the child’s quality of life, even
greater than the child’s cognition (Connolly et al., 2006). Similarly, it has been reported
that children with epilepsy, two years post-diagnosis, compared to the general population
maintain lower scores on the emotional impact of epilepsy on parents, (Speechley et al.,
2012). Taylor et al. (2011), highlighted that an important step when determining if a
patient with new-onset epilepsy is at risk of poor HRQL is to consider the psychosocial
status of the family as well as the child’s psychosocial status. One psychosocial factor
that has been investigated is anxiety. It has been found that among CWE, parental anxiety
outweighed children’s epilepsy-related clinical characteristics as a predictor of children’s
HRQL (Yong et al., 2006).
In addition, parental coping is another factor of parental mood and mental health that has
been investigated to influence HRQL. McLaughlin et al., (2018), demonstrates the unique
role that parental coping has in youth with epilepsy’s HRQL; such that, parental coping is
significantly related and predicts lower scores of HRQL in youth with epilepsy.
Overall, understanding that parental mood and mental health affects CWE’s HRQL
highlights the need for family-based interventions and addressing the whole family
during treatment (McLaughlin et al., 2018). Addressing non-medical features that have
potential to be modifiable shows promise for improving parental mood and mental health
with the hope, of in turn, of improving children’s HRQL (Jain et al., 2018).
In conclusion, research supports that HRQL of children with epilepsy is a multidimensional patient reported outcome that is associated with psychosocial health, family
environment and parental mental health. Therefore, targeting interventions to include the
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family unit may be useful when addressing a child’s HRQL (Im et al., 2019; Jain et al.,
2018; Puka, Tavares, et al., 2018).

2.3.3

Psychiatric Comorbidities and Psychosocial Factors

In general, 70% of people with epilepsy become seizure free over time, placing an
emphasis on understanding long term effects of comorbidities that may persist after
seizures are gone (World Health Organization, 2019). Amongst children with epilepsy,
comorbid conditions are common, with population estimates reaching upwards of 70%
(Pastor et al., 2015; Sillanpää & Cross, 2009). Psychiatric comorbidities are the most
prevalent comorbidities in children with epilepsy with reported prevalence reaching
between 29-40%, which is higher than in the general population (Global Burden of
Disease Collaborative Network, 2017). Identifying psychosocial problems at diagnosis of
epilepsy in children is needed to address psychiatric comorbidities (Reilly et al., 2015;
Taylor et al., 2011). This section will focus on psychosocial factors and psychiatric
comorbidities.
Children with new-onset epilepsy, particularly those with comorbidities, are at risk for
reduced HRQL at the time of diagnosis. Psychosocial support has been identified as key
to addressing reduced HRQL in children (Taylor et al., 2011). Results from Baca,
Vickrey, Caplan, Vassar, & Berg (2011), were consistent with the need to expand the
focus from solely seizure related factors. Baca et al., (2011) determined that psychiatric
comorbidities are associated with long-term HRQL in children with epilepsy.
Furthermore, resolution of seizures does not ensure that comorbidities cease to affect
children with epilepsy; importantly, the association of psychiatric comorbidities with
worse HRQL is stronger than the association of seizure remission status with better
HRQL (Baca et al., 2011). Additional studies have supported that the effect of epilepsy
on HRQL in children arises through psychiatric factors (Bilgic, Isik, Sivri Colak, Derin,
& Caksen, 2018). Highlighting the importance of non-seizure related factors, such as
psychosocial aspects of health leads to identifying predictors that may be amenable to
change and influence how we treat children diagnosed with epilepsy (Ferro et al., 2017).
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Mood disorders such as, depressive and anxiety disorders, are some of the most common
psychological comorbidities (Wei & Lee, 2015). Depression and anxiety are reported in
12-26% of children with epilepsy (Wei & Lee, 2015). Depressive symptoms have been
found to be the strongest predictor of HRQL in children with epilepsy, over and above
clinical and seizure factors (Sano et al., 2014). Specifically, symptoms of depression were
more predictive of HRQL than seizure type, seizure duration and number and effects of
anti-epileptic drugs (AEDs). That is not to say that number of AEDs did not have an
effect, but the effect of AEDs was not as strong as depressive symptoms on HRQL (Sano
et al., 2014). Symptoms of anxiety have been found to be independently and significantly
related to QOL in children with epilepsy (Reilly et al., 2015). Understanding how
psychosocial factors and mood disorders affect children with epilepsy may lead to
changes in treatment and interventions when a child is diagnosed with epilepsy.
Overall, research has shown that psychiatric comorbidities are the most prevalent
comorbidities in children with epilepsy (Global Burden of Disease Collaborative
Network, 2017). Experiencing psychiatric comorbidities can negatively affect children’s
HRQL (Bilgic et al., 2018). Additionally, information collected through the measurement
of psychosocial factors can be used to identify children at risk for diminished HRQL
(Taylor et al., 2011; World Health Organization, 2019). Understanding the effects of
modifiable factors, identifying them in patients, developing treatments and intervening
early is pertinent to improving quality of life of children with epilepsy (Taylor et al.,
2011).

2.3.4

Longitudinal Studies of Childhood-Onset Epilepsy

Cross sectional designs have often been adopted in studying the effects of epilepsy on
children’s HRQL. Studies identify a group of children recently diagnosed with epilepsy,
evaluate their HRQL, compare them to the general public and/or identify predictive
factors of HRQL (Momeni, Ghanbari, Bidabadi, & Yousefzadeh-Chabok, 2015; Sabaz et
al., 2003). These studies have identified important factors related to HRQL and
highlighted the impact of an epilepsy diagnosis on children and their families (Momeni et
al., 2015; Sabaz et al., 2003). The importance has been recognized of conducting of
longitudinal studies that focus on HRQL over time (Momeni et al., 2015) as well as those
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that focus on identifying predictors of HRQL over time that are amenable to change
through intervention (Ferro et al., 2014; Ferro, Landgraf, et al., 2013).
Longitudinal studies of children with epilepsy are sparse but do exist. For example, a
long-term study from Nova Scotia identified a cohort of children diagnosed with
idiopathic generalized epilepsy from 1977 to 1985. In 2008 to 2009, patients were
contacted and asked questions that focused on social and medical outcomes. It was
determined that 75% of those who responded obtained complete remission at follow up,
an average of 22 years after diagnosis. The study also identified that unsatisfactory social
outcomes and learning problems were common (Camfield & Camfield, 2010). This study
also provided valuable information regarding remission status in a specific type of
epilepsy. However, it lacked a comprehensive measure of HRQL, and measurements
were not taken consistently throughout the follow up period.
Another study was published from a population based cohort in Finland (Sillanpaa,
Haataja, & Shinnar, 2004). This study followed children younger than 16 years old with
active epilepsy between 1961 to 1964. Participants were followed prospectively until
1997. Participants were contacted and questionnaires on HRQL and psychosocial health
outcomes were completed. Participants were compared to population-based controls.
Results highlighted that subjects on medication, regardless of remission status had lower
scores on general and epilepsy-specific measures of QOL than controls or those off
medication. It was determined that childhood-onset epilepsy had persistent long-term
impacts on HRQL, especially amongst those still on medication (Sillanpaa et al., 2004).
Studies such as Sillanpaa et al., (2004) and Camfield and Camfield (2010) provided
essential information regarding the long-term impact of an epilepsy diagnosis in
childhood. However, neither study was able to collect repeated measurements throughout
the follow up period and thus information is unavailable on the course of HRQL leading
up to the final long-term assessment.
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2.4

Limitations of Previous Studies

Studies of HRQL in children with epilepsy are often conducted using cross-sectional or
short-term cohort designs (Momeni et al., 2015; Sabaz et al., 2003). Cross-sectional
studies can provide important information regarding a child and their families
experiences with an epilepsy diagnosis and their HRQL. However, cross-sectional studies
are unable to provide information regarding the impact of epilepsy on HRQL over time.
In contrast, longitudinal research has the potential to offer information to parents
regarding prognosis and the potential course for their child’s HRQL later in life.
Currently, most longitudinal research in children with epilepsy relies on retrospective
cohorts, comparing with age-matched controls, or single measurements from a cohort in
the past (Camfield & Camfield, 2010; Sillanpaa et al., 2004). Additionally, to compare to
normative populations with the intent to understand the impact of epilepsy on children,
requires the use of a generic measure of HRQL, as opposed to disease-specific
questionnaires.
The second phase of HERQULES extended the window of observation from the 2-year
follow up, to 8-10 years later—presenting the opportunity to describe the long-term
course of HRQL. To date results from that study have only been reported using a diseasespecific measure of HRQL (Puka et al, 2020), but what remains to be assessed is the
long-term course of HRQL, using a generic measure and comparing these outcomes to a
normative sample.
To date, little is known about the factors associated with the course of HRQL for children
with epilepsy in the long-term. Important steps in understanding the course of HRQL in
the long-term include, measuring how levels of HRQL in children with epilepsy compare
to levels in the general population and what factors contribute to improvement, decline or
stable HRQL in children with epilepsy. Understanding what factors are associated with
positive HRQL and how children with epilepsy compare to their age-matched peers, may
aid parents to make informed decisions regarding their child’s health care.
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Chapter 3

3

Study Purpose and Research Objectives

3.1

Study Purpose

Children with epilepsy have poorer health-related quality of life (HRQL) than their peers
in the general population (Bansal et al., 2017). To date, most of what we know about
HRQL in children with epilepsy is based on cross-sectional or short-term follow-up after
diagnosis. Far less is known about the long-term course of HRQL for those with
childhood-onset epilepsy and the factors associated with it. The proposed research will
contribute to understanding long-term HRQL associated with childhood-onset epilepsy,
how HRQL in the long term compares to levels in the general population, and what
factors contribute to improvement, decline or stability in HRQL over time.
Understanding what factors are associated with positive HRQL and how those with
childhood-onset epilepsy compare to their age-matched peers may aid parents and
clinicians in knowing what to expect and making informed decisions regarding health
care for these children.

3.2

Research Objectives

The overall aim of the thesis is to describe the long-term course of HRQL in those
diagnosed with childhood-onset epilepsy. There are three research objectives:

1. To evaluate HRQL associated with childhood-onset epilepsy eight years postdiagnosis.
Related to this objective is one specific research question:
1.1. How do average levels of HRQL in those with childhood-onset epilepsy eight
years later compare to levels reported for age-matched peers in the general
population?
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2. To describe the course of HRQL over 8 years after the diagnosis of childhood-onset
epilepsy.

Related to this research objective are three specific research questions:

2.1. What is the unadjusted average estimated course of HRQL from baseline to eight
years later?
2.2. Which characteristics around the time of diagnosis of childhood-onset epilepsy
are associated with physical and psychosocial health summary subscale scores
for HRQL eight years later?
2.3. What is the average estimated course of HRQL from baseline to eight years later,
while accounting for associated baseline characteristics?

3. To determine the change in HRQL over the 8 years following a diagnosis of
childhood-onset epilepsy.

Related to this objective, the change in HRQL will be explored through two research
questions:
3.1. For what proportion of those with childhood-onset epilepsy does HRQL eight
years after diagnosis improve, worsen or not change from that reported around
the time of diagnosis?
3.2. For what proportion of those with childhood-onset epilepsy does HRQL eight
years after diagnosis improve, worsen or not change from that reported two years
post-diagnosis?
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Chapter 4

4

Methods

This chapter presents details of the methods used for this project. The chapter starts with
an overview of the source of the data. A brief description of the sampling method and
study design is included. Following the study design, a description of the measurement
tools used is provided. The chapter concludes with a description of the statistical
methods.

4.1

Study Design and Sample

The data used for this research come from the HEalth-Related QUality of Life in
Children with Epilepsy Study (HERQULES), which is a multi-center prospective cohort
study of children with epilepsy in Canada. The study recruited families of newly
diagnosed cases of epilepsy in children, recorded details regarding their epilepsy,
measured their health-related quality of life (HRQL), documented other factors such as
family environment, and followed the cohort for about 10 years since diagnosis.
For the first stage of sampling, all paediatric neurologists who were members of the
Canadian Association of Child Neurology or added to the sampling frame by a panel of
experts were invited to the study. A total of 72 members were contacted, of whom 53
(74%) agreed to participate. Research ethics approval was obtained from the 17
applicable research ethics boards across Canada (Western University Health Science
Research Ethics Board file #10069E).
The second stage of sampling included recruiting eligible patients to be included in the
study. Inclusion criteria for the HERQULES cohort were a new case of epilepsy in a
child aged 4-12 years with no prior epilepsy diagnosis; parents were required to have
primary responsibility over the child at least for the prior six months and have sufficient
English language skills to complete questionnaires. Families were not eligible if their
child had an additional diagnosis of a progressive or degenerative neurological disorder
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or other major comorbid non-neurological physical disorder likely to impact their HRQL,
such as asthma requiring daily medication or renal failure. Once identified as eligible for
the study, parents received information regarding the study with detailed information
regarding what participation would entail.
In the first phase of HERQULES, parents completed questionnaires, by mail, at four time
points: at the time of diagnosis (baseline), 0.5, 1, and 2 years post-diagnosis. The
questionnaires were designed to measure their child’s HRQL, family factors, and
demographic information. Parents’ questionnaire took approximately 45-60 minutes to
complete at each time. Parents also provided consent for their child’s neurologist to
provide clinical information at the same times. Neurologists provided clinical information
such as severity of epilepsy, seizure type, and treatment. Physicians’ questionnaire took
approximately 5-7 minutes to complete each time. At baseline, the sample consisted of
456 eligible children; parents of 374 (82%) returned completed initial questionnaires. At
the 2-year follow-up, 283 (62%) parents returned questionnaires. Throughout
HERQULES, the Tailored Design Method was followed to optimize the response rate
and quality of data obtained (Dillman, 2007).
In the second long-term follow-up phase of HERQULES, families were contacted for
follow up at approximately the 8- and 10-years post-diagnosis, at which time self-report
by the adolescents and young adults with epilepsy was introduced. Data from
parents/caregivers and the participants’ neurologists were collected using a mailed survey
at both the 8- and 10-year follow-up. Due to the established approval across Canada from
the first phase of HERQULES, approval for second phase of HERQULES was required
only from the Western University Health Sciences Research Ethics Board (file #102819).
At the 8-year follow-up, 168 parents returned completed questionnaires of participants
who were still less than 18 years old.
My role in in the study entailed: developing research objectives for this thesis, conducting
a literature review of the topics pertinent to the proposed research objectives, conducting
statistical analyses under the supervision of my thesis supervisory committee, interpreting
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and summarizing the results of the statistical analyses, and making conclusions based on
the results.

4.2

Measures

Below is a description of the measurement tools used in HERQULES that pertain to the
current project. The description of these tools is organized into parent report and
physician report instruments. The baseline parent report questionnaire is included in
Appendix A.

4.2.1

Parent Report

Sociodemographic Information
Sociodemographic information collected from parents included: child’s sex and date of
birth and parent’s age, sex, marital status, employment status, education and annual
household income. The current study dichotomized marital status into married or not
married, with a value of one indicating married, and employment status into employed or
not employed, with a value of one indicating that the parent is employed part or full time.
Higher values for both education and income in the current study indicate higher levels of
education and income. Values for income started at 10 000 dollars or less and increased
by 10 000-dollar increments until 99 000 dollars followed by a final option of greater
than 100 000 dollars.

Health-Related Quality of Life
Child Health Questionnaire-Parent Form (CHQ PF-50)
The CHQ is a generic health status tool (Landgraf, Abetz, & Ware, 1996). The
questionnaire is validated for parent-report of HRQL for children ages 5-18 years in the
general population as well as those with various acute and chronic health conditions.
The CHQ-PF-50 is the 50-item, parent-report version. The response options for the CHQ
are ordinal and vary by the item. Each item consists of 4–6 response options.
Additionally, each scale consists of a varying number of items. Most scales have a recall
period of four weeks. The change in health subscale has a recall period of one year, and
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both the family cohesion and general health scales rely on the child’s health “in general”.
From the questionnaire, two summary scores, psychosocial and physical health, and
fourteen subscale scores can be calculated for a detailed assessment of individual
domains of HRQL to help target and develop specific interventions (Landgraf, Abetz and
Ware, 1996). Each summary score is standardized and weighted with a mean of 50 and a
standard deviation of 10. For each subscale and summary score, the higher the score, the
more positive the outcome. For example, a higher score on the bodily pain sub-scale is
interpreted positively as less pain and limitations due to pain.
The CHQ PF-50 is a well-validated and reliable measure (Hullmann et al., 2011;
Landgraf et al., 1996). Internal consistency and test-retest reliability have been found to
be good across normative samples and those with health conditions (Landgraf et al.,
1996; Raat, Bonsel, Essink-Bot, Landgraf, & Gemke, 2002). In the first phase of
HERQULES, Cronbach’s alpha coefficients ranged from 0.86 to 0.89 (Speechley et al.,
2012). Cronbach’s alpha is a measure of internal consistency, specifically, determining
whether a scale is reliable and that a set of items are measuring the same construct
(Cronbach, 1951). Cronbach’s alpha is measured on a scale from zero to one. A
Cronbach’s alpha closer to one typically indicates a higher degree of internal consistency
(Cronbach, 1951). Construct and convergent validity have been evaluated. Construct
validity has been found to be good (Brunner et al., 2009; Drotar, Schwartz, Palermo, &
Burant, 2006). Convergent validity is considered good based on associations observed
between scores on the CHQ PF-50 compared to other pediatric quality of life measures
(Brunner et al., 2009). A confirmatory factor analysis of the CHQ in the HERQULES
sample provided evidence that the higher-order summary factor structure of the CHQ is
robust over time (Ferro, Landgraf, et al., 2013).

Family Environmental Factors
Family Adaptability, Partnership, Growth, Affection, and Resolve (Family APGAR)
The Family Adaptability, Partnership, Growth, Affection, and Resolve (Family APGAR)
scale assesses satisfaction with family relationships (Smilkstein, 1978). It has five-items
and uses a five-point Likert scale (0–4) with higher scores indicating greater satisfaction.
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The APGAR has been shown to be valid and reliable in clinical and research settings
(Smilkstein, 1978; Smilkstein, Ashworth, & Montano, 1982). In the current sample,
Cronbach’s alpha coefficient was 0.87 (95% CI: 0.85-0.89)
Family Inventory of Resources for Management (FIRM)
The Family Inventory of Resources for Management (FIRM) assesses what social,
psychological, community and financial resources, families have available to aid them in
adapting to stressful events (McCubbin, Thompson, & McCubbin, 1996). Respondents
rate how each statement describes their family situation with response options ranging
from 0 (not at all) to 3 (very well). The FIRM has 24 questions that are summed for a
total score. Higher scores indicate greater resources. The FIRM has demonstrated
adequate reliability and validity (McCubbin et al., 1996). In the current sample,
Cronbach’s alpha coefficient was 0.90 (95% CI: 0.88-0.91).
Family Inventory of Life Events and Changes (FILE)
The Family Inventory of Life Events and Changes (FILE) is a 71-item self-report
questionnaire of family stress in the previous year across nine domains (McCubbin et al.,
1996). Scores are tabulated for each domain and a total “pile-up” scale by counting the
number of events experienced. The FILE’s reliability and validity are well-established
(McCubbin et al., 1996). In the current sample, Cronbach’s alpha coefficient was 0.84
(95% CI: 0.82-0.86).
Center for Epidemiological Studies Depression Scale (CES-D)
The Center for Epidemiological Studies Depression Scale (CES-D) is a 20-item measure
that assesses frequency of symptoms of depression over the past week (Radloff, 1977).
The CES-D uses a four-point Likert scale, with total scores ranging from 0-60. The total
score is calculated by summing all item responses, with a higher score indicating greater
impairment. The factor structure of the CES-D has been established in adult women from
the HERQULES sample; providing support that the scale is longitudinally invariant and
changes in scores over time reflect true changes in depressive symptoms (Ferro &
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Speechley, 2013). In the current sample the Cronbach’s alpha coefficient was 0.97 (95%
CI: 0.96-0.98).

4.2.2

Physician Report

Severity of Epilepsy (GASE)
The overall severity of epilepsy was measured at baseline using the Global Assessment of
Severity of Epilepsy (GASE) Scale (Speechley et al., 2008). The GASE Scale is a single
item, 7-point global scale created to provide clinicians with a simple and efficient tool
that categorizes patients by severity of illness. The single question asked is: “Taking into
account all aspects of this patient’s epilepsy, how would you rate its severity at his/her
last visit? Please check one answer”. The response options are: (1) extremely severe, (2)
very severe, (3) quite severe, (4) moderately severe, (5) somewhat severe, (6) a little
severe, (7) not at all severe. The GASE is considered to have adequate construct validity,
stability and responsiveness to clinical changes as well as good intra- and inter-rater
reliability (Chan, Zou, Wiebe, & Speechley, 2015; Speechley et al., 2008).
Seizure Type
Neurologists reported epilepsy characteristics such as seizure type and epilepsy syndrome
of each patient, according to International League Against Epilepsy (ILAE)
classifications (ILAE, 1989). For the current analyses, values were collapsed into three
epilepsy syndrome categories: generalized, focal/partial, and undetermined.
Behavioural Problems
The physician questionnaire included the following question: “Does the patient have
behavioural problems?”. If the answer was yes, then physicians reported on the severity
of the behavioural problems on a 3-point scale, (1) mild, (2) moderate, (3) severe and
provided the diagnoses. The current study dichotomized this variable as the presence or
absence of behavioural problems.
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Cognitive Problems
The physician questionnaire included the following question: “Does the patient have
cognitive problems?”. If the answer was yes, then physicians reported on the severity of
the cognitive problem on a 4-point scale, (1) borderline, (2) mild, (3) moderate, (4) severe
and provided the diagnoses. The current study dichotomized this variable as the presence
or absence of cognitive problems.

4.3

Methods of Statistical Analysis

All analyses were conducted using STATA/SE 13.0 software for Mac (StataCorp LP.,
College Station, TX, USA). Analyses are described below in the order of the three
objectives and their respective research questions as presented in Chapter 1.

4.3.1

Objective 1

To evaluate HRQL associated with childhood-onset epilepsy eight years post-diagnosis.
The research question associated with Objective 1, (How do average levels of HRQL in
those with childhood-onset epilepsy eight years later compare to levels reported for agematched peers in the general population?) were addressed as described below
Summary statistics and frequency distributions of sample characteristics were used to
describe the sample at baseline, 2-year and 8-year follow up. Scale scoring was
completed as outlined by the CHQ User’s Manual (Landgraf et al., 1996). Reverse
scoring was completed where necessary. Reverse scoring is the process of recoding the
response options of an item in a questionnaire, so the numerical scoring runs in the
opposite direction of the original question. This is done in the CHQ to ensure all items
are positively scored, such that a higher numerical score indicates better health than a
lower score. Scores are imputed, using mean substitution, for those individuals with
missing items, provided that the respondents answered at least half of the items in the
scale. Raw subscale scores were computed and then transformed to range from 0 to 100,
with a higher score indicating better health. To calculate the two-summary score means
(psychosocial and physical health) for the sample, ten of the CHQ scales are standardized
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using means and standard deviations from the general U.S. population and six clinical
samples. The scales are then aggregated using weights from the same normative and
clinical data sets. Then, the aggregate scores are standardized using a linear T-score
transformation—resulting in a mean of 50 and a standard deviation of 10. Then, CHQ
subscale and summary scores were compared between the study sample and a population
normative sample (Landgraf, Abetz, and Ware, 1996) using two sample t-tests. P-values
are reported along with the confidence interval of the sample mean differences.

4.3.2

Objective 2

Assess the extent to which characteristics around the time of diagnosis with childhoodonset epilepsy are associated with HRQL eight years later. Furthermore, describe the
course of HRQL over 8 years while accounting for associated characteristics.
The first research question associated with this objective (What is the unadjusted average
estimated course of HRQL from baseline to eight years later?) was addressed by the
analyses described here.
A mixed-effects model was used to examine the course of HRQL measured at baseline,
0.5, 1, 2, and 8 years later for the psychosocial and physical health summary scores
(Laird & Ware, 1982). The model has the following form.
𝑦𝑖𝑗 = 𝑏0𝑗 + 𝑏1𝑗 𝑇𝑖𝑗 + 𝑏2𝑗 𝑇𝑖𝑗2 ,
with
𝑏0𝑗 = 𝑏0 + 𝑢0𝑗 , 𝑏1𝑗 = 𝑏1 + 𝑢1𝑗 , 𝑏2𝑗 = 𝑏2 + 𝑢2𝑗
where 𝑦𝑖𝑗 is the outcome of subject 𝑗 at occasion 𝑖, 𝑇𝑖𝑗 is the corresponding time since
diagnosis and was treated as continuous, 𝑏0𝑗 is the intercept, and 𝑏1𝑗 and 𝑏2𝑗 are the
coefficients of linear and quadratic relationships between time and outcome. These
coefficients have mixed effects that comprise a sample average fixed effect (𝑏0 , 𝑏1 , 𝑏2 )
and a subject-specific random effect (𝑢0𝑗 , 𝑢1𝑗 , 𝑢2𝑗 ), which are assumed to be normally
distributed with means of 0 and variance-covariance to be estimated. In this thesis, an
unstructured variance-covariance matrix was adopted, because the variances of the
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random effects are unlikely to be the same since they describe different aspects of the
individual curves. Individual differences were assessed by estimating a random
coefficient representing variability around the averaged intercept and the slope.
Therefore, the mixed-effects model consists of the fixed effects, given by 𝑦 = 𝑏0 +
𝑏1 𝑇 + 𝑏2 𝑇 2, to describe the average curve, and the random effects to account for the
individual departures from the average curve. One can recognize that in the fixed effect
model, 𝑏0 represents the average outcome at time 0, 𝑏1 and 𝑏2 together represent the
outcome change per unit time, or the rate of the outcome changes over the follow up
time.
Mixed effect models are a commonly used approach for the analysis of repeatedmeasures data and provide estimates of the average change in a sample, accounting for
correlations between repeated measures, missing data, and variations in the
measurements of time (Singer & Willett, 2003). No covariates were added to the model,
solely the effect of time on HRQL was estimated.
The second research question associated with this objective (which characteristics around
the time of diagnosis with childhood-onset epilepsy are associated with physical and
psychosocial health summary subscale scores of HRQL measurements eight years later?)
was addressed by the analyses described below.
Associations between baseline risk factors and the CHQ, physical and psychosocial
health summary scores 8 years later were calculated using Pearson correlations and
ANOVA. P values, r values, and F values are presented. r values indicate the strength of a
linear association between two continuous variables. F values provide an indication of the
significance of a group of categorical variables; such that, a high F value indicates a high
joint effect of all groups compared to the outcome variable.
The third research question associated with this objective (what is the average estimated
course of HRQL from baseline to eight years later, while accounting for associated
baseline characteristics?) was addressed by the analyses outlined below.
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To investigate the effect of baseline characteristics on the psychosocial and physical
health summary scores over time, the model from the first question associated with
Objective 2 was expanded. Specifically, the model takes the following form:
𝑦𝑖𝑗 = 𝑏0𝑗 + 𝑏1𝑗 𝑇𝑖𝑗 + 𝑏2𝑗 𝑇𝑖𝑗2 + 𝑎1 𝑋1 + 𝑎2 𝑋2 + ⋯ + 𝑎𝑝 𝑋𝑝
where 𝑋1 to 𝑋𝑝 and 𝑎1 to 𝑎𝑝 denote 𝑝 baseline characteristics and their corresponding
effects on a trajectory. Factors retained in the final model were selected using the Akaike
information criterion (AIC) and Bayesian information criterion (BIC) statistics, with
smaller values suggesting better models. Residues from the models were subjected to
examination of assumptions using scatter plots. The model included baseline
characteristics selected from bivariate analyses with p < 0.20 used as the criterion
(Maldonado & Greenland, 1993). The guideline of 10 observations per variable was also
considered when deciding the maximum number of characteristics to be included in the
mixed-effects model (Peduzzi, Concato, Feinstein, & Holford, 1995). Both linear and
quadratic terms for time were considered.

4.3.3

Objective 3

To determine the change in HRQL over the 8 years since diagnosis.
The two research questions that are associated with this objective (For what proportion of
those with childhood-onset epilepsy does HRQL eight years after diagnosis improve,
worsen or not change from that reported around the time of diagnosis? And for what
proportion of those with childhood-onset epilepsy does HRQL eight years after diagnosis
improve, worsen or not change from that reported two years post-diagnosis?) were
addressed by the analyses described below.
The two CHQ subscales psychosocial health and physical health were considered the
outcomes to be assessed in two parallel analyses. Change scores from baseline to 8 years
and 2 years to 8 years were computed for both the psychosocial and the physical health
summary scores. As a minimal clinically important difference has not been established
for the CHQ-PF50 to date, change scores greater than or equal to 0.5 of a standard
deviation were considered clinically important (Rai et al., 2015). Scores were then
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grouped as improved, worsened or no change. Proportions of the samples in each of these
categories are reported along with confidence intervals.
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Chapter 5

5

Results

This chapter presents the results for this thesis. The first section describes the
characteristics of the sample studied. The following sections describe the findings related
to each of the research objectives and the associated research questions.

5.1

Sample Characteristics

At baseline, 374 children were included in the sample. Children were on average, 7.5
years old (SD = 2.3) and 52.3% were male. The majority of primary caregivers
participating were a biological parent (94.1%) and female (92.7%). Of parents, the
majority was married (79.6%), employed (66.5%), and had obtained post-secondary
education (66.5%). The characteristics of adolescents, their parents and their families at
baseline, 2- and 8-year follow-ups are summarized in Table 5.1.
At the 2-year follow up, 281 children were included in the sample. 85.7% of the sample
had physician report data (n = 241) for epilepsy specific characteristics. The majority was
diagnosed with localization-related epilepsy syndrome types (60.2%). At 2 years postdiagnosis, 31% were experiencing seizures, 21-9% were reported to have behavior
problems and 28.1% to have cognitive problems.
At the 8-year follow up, 191 adolescents were included in the sample. This thesis focuses
on a sub-sample aged 18 years and younger at the 8-year follow up. A total of 168
adolescents, 18 years or younger, 88.0% of the sample at 8-year follow up, were included
in the analyses reported here. The average age of these adolescents was 15.0 years old
(SD = 2.1). At 8 years post-diagnosis, 54.8% of adolescents were male. Of the sample at
8 years post-diagnosis, only 21% had a physician report on epilepsy specific
characteristics since the vast majority of adolescents were no longer receiving any care
for epilepsy. Thus, epilepsy-related characteristics at the 8-year follow-up were not
analysed.
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When comparing baseline characteristics, parents who remained in the sample to
participate in the 8-year follow-up, had more education (p = 0.001), a higher household
income (p < 0.0001), lower scores on depression symptoms, higher family functioning
scores (p = 0.0415), higher family resources scores (p < 0.0001), lower scores on family
demands (p = 0.0003) and their children were older (p = 0.0021) and less likely to have a
cognitive problems (p = 0.001) than those who participated in the study initially but were
lost to follow-up. There were no baseline significant differences in the two groups on the
age (p = 0.2802), employment (p = 0.175), or marital status (p = 0.055) of the parent or
the child’s diagnosed epilepsy syndrome (p = 0.284), number of AEDs taken (p = 0.382),
frequency of seizures (p = 0.226), severity of epilepsy (p = 0.069), or whether the child
had behavioural problems (p = 0.160).
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Table 5.1: Summary characteristics of sample at baseline at 2 years and 8 years after
diagnosis.

Children’s Characteristics
Age in years, mean (SD)
Sex, % male
Epilepsy syndrome type, %
Generalized epilepsies
Localization-related (partial/focal epilepsies)
Not determined whether focal or generalized
Taking antiepileptic drugs, %
Experiencing seizures, %
Severity of Epilepsy, GASE, mean (SD)
Comorbidities, %
Behavioural problems, %
Cognitive problems, %
Family Characteristics
Parent’s age in years, mean (SD)
Parent’s sex, % female
Parent’s marital status, % married
Parent’s employment status, % employed
Education, % post-secondary
Annual household income, %
<$39,999
$40,000—59,999
$60,000—79,999
$80,000
Depressive symptoms, CES-D, mean (SD)
Functioning, Family APGAR, mean (SD)
Resources, FIRM, mean (SD)
Demands, FILE, mean (SD)
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Baseline
(n = 374)

2 Years
(n= 281)

8 Years
(n=168)

7.5 (2.3)
52.3

10.0 (2.3)
52.0

15.0 (2.1)
54.8

38.8
59.3
1.9
67.1
93.4
5.4 (1.2)

37.3
60.2
2.5
75.4
31.3
6.3 (1.0)

—
—
—
—
—
—

15.1
20.0

21.9
28.1

—
—

38.2 (6.1)
92.7
79.6
66.5
66.5

40.8 (5.6)
92.9
82.1
75.7
75.0

46.1 (5.4)
94.1
82.1
82.7
82.6

20.9
20.1
18.0
34.9
14.3 (10.3)
13.9 (3.8)
50.1 (11.1)
9.5 (6.5)

14.2
17.1
18.9
41.6
11.8 (9.9)
14.1 (3.9)
50.7 (11.5)
7.8 (5.7)

7.8
9.6
11.4
67.4
10.4 (9.2)
14.5 (3.6)
52.7 (11.2)
8.3 (5.8)

5.2

Objective 1

To evaluate health-related quality of life (HRQL) associated with childhood-onset
epilepsy eight years post-diagnosis.
Presented here are the results from the research question associated with Objective 1,
(How do average levels of HRQL in those with childhood-onset epilepsy eight years later
compare to levels reported for age-matched peers in the general population?).
Average levels of HRQL in the HERQULES sample at 8 years post-diagnosis were
compared to the normative data collected from a general United States (U.S.) population
sample of women who were parents of 252 children aged 5-18 years using the Child
Health Questionnaire Parent-Form (CHQ-PF50). Two-sample, independent, t-tests were
completed comparing the normative sample and the epilepsy sample for each of the 14
CHQ subscales and the two summary scores.
Results are summarized in Table 5.2. The epilepsy sample scored higher than the
normative sample on three scales, general health (p = 0.0240), bodily pain (p = 0.0117)
and family-cohesion (p = 0.0103). The epilepsy sample scored lower than the normative
sample on one scale related to child, role/social limitations—emotional-behavioral (p =
0.0281), and two scales related to family, family-limitations in activities (p = 0.0047),
and parental impact-emotional (p < 0.0001). The largest difference between the
normative sample and the epilepsy sample was on the emotional impact on parents,
which was 10 points lower on average in the epilepsy sample compared to the normative
population. There was no significant difference between the epilepsy and normative
sample on the remainder of subscales or the two summary scales.
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Table 5.2: Average levels of HRQL compared between HERQULES sample at 8 years
and U.S. normative data

CHQ Score

HERQULES

U.S. normative data

(8 years)

(n = 252)

N

Mean

SD

CI (95%)

Mean

SD

P value

Physical Functioning

168

94.3

15.1

92.0-96.6

95.6

15.3

0.3955

Role/Social-Physical

166

92.3

21.8

88.9-95.6

93.2

20.3

0.6560

General Health

168

76.5

17.1

73.8-79.1

72.5

17.8

0.0240

Bodily Pain

166

85.2

21.0

82.0-88.5

80.2

19.2

0.0117

Family Activities

168

83.7

21.1

80.5-86.9

89.4

19.6

0.0047

166

87.6

24.9

83.7-91.4

92.1

19.6

0.0381

Parental Impact-Time

168

87.6

20.9

84.4-90.8

87.2

20.5

0.8590

Parental Impact-Emotional

168

69.0

26.6

64.9-73.1

79.1

19.9

<0.0001

Self Esteem

166

76.9

19.4

73.9-79.9

78.7

16.9

0.3161

Mental Health

167

78.0

16.8

75.4-80.5

78.2

13.0

0.8719

Behaviour

167

74.8

19.5

71.8-77.8

75.1

17.1

0.8719

Family Cohesion

168

77.3

20.7

74.1-80.4

71.9

21.2

0.0103

Physical Summary Score

164

53.7

8.9

52.3-55.1

52.7

9.4

0.2800

Psychosocial Summary Score

164

49.3

11.7

47.5-51.1

50.9

9.0

0.1199

Role/Social
Emotional/Behavioural
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5.3

Objective 2

To describe the course of HRQL over 8 years after the diagnosis of childhood-onset
epilepsy.
The results from the research question associated with Objective 2 (What is the
unadjusted average estimated course of HRQL from baseline to eight years later?) are
presented here.
The unadjusted mixed-effects model tested the effect of changes in scores over time,
without accounting for predictors of change. Separate parallel analyses were conducted
for psychosocial and physical health summary scores. Both linear and quadratic terms for
time were tested for each of the two models.
Psychosocial health scores were visually inspected using a scatter plot, which is
presented in Figure 5.1. The quadratic term for time was statistically significant and
remained in the model (p = 0.002) (Table 5.3). Individual differences among participants
were assessed by estimating a random coefficient representing variability around the
averaged intercept and the slope. The mean intercept of 46.7 describes the average
psychosocial health score at baseline, the years term describes the gradient or rate of
growth in the unit of years, and the quadratic years term represents the multiplicative
acceleration in psychosocial health scores and the shape of the curve. The years term and
the quadratic years term must be interpreted together. In the unadjusted model, the
average psychosocial health score at baseline was 46.7, and adolescents’ scores increased
by 1.6 points each year. There was a decreasing growth rate over time, as indicated by a
negative coefficient for the quadratic time, here being the years since diagnosis variable;
indicating a slowing of growth over time. In other words, the results suggest that at time
zero, if the slope of psychosocial health scores were to remain unchanged, scores would
linearly increase by an average of 1.6 points each year. However, as the quadratic term is
significant and negative, this indicates that for each year’s increase—the slope reduces by
the coefficient for the quadratic term of time multiplied by two, or, 0.32 of a psychosocial
health unit. CHQ scores for psychosocial health appear to increase until 2 years postdiagnosis at which time HRQL remains stable until 8 years. The average psychosocial
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health summary score growth curve model for unadjusted psychosocial health scores over
8 years is provided in Figure 5.1.

Figure 5.1: Scatter plot with connected lines and average psychosocial health summary
score growth curve model for unadjusted psychosocial health scores over 8 years.
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Table 5.3: Growth curve models of psychosocial health summary scores across 8 years in
those with childhood-onset epilepsy
Level-1, Unadjusted
Variable

regression, including

Level-2, adjusted

quadratic term for

regression

time
 (standard error) P

 (SE) P

Intercept

46.71 (0.77) <0.0001

34.30 (6.50) <0.0001

Years

1.57 (0.43) <0.0001

1.42 (0.43) 0.001

Years2

-0.16 (0.05) 0.002

-0.14 (0.05) 0.006

Age at baseline

-0.47 (0.62) 0.449

Age at seizure onset

1.06 (0.61) 0.080

Epilepsy severity (GASE)

0.04 (0.52) 0.943

Parental Depressive Score

-0.11 (0.08) 0.181

(CES-D)
Family Functioning (APGAR)

0.28 (0.22) 0.205

Family Resources (FIRM)

0.26 (0.09) 0.002

Family Demands (FILE)

-0.07 (0.13) 0.572

Cognitive Problems
Variance (Intercept)

-6.76 (1.91) <0.0001
77.74 (11.27)

45.80 (8.09)

Variance (Years)

4.32 (4.22)

3.51 (3.97)

Variance (Years2)

0.05 (0.06)

0.04 (0.06)

Covariance (Intercept, Years)

0.72 (4.98)

1.37 (4.20)

Covariance (Intercept, Years2)

-0.23 (0.59)

-0.36 (0.49)

Covariance (Years, Years2)

-0.45 (0.51)

-0.33 (0.47)

Log restricted-likelihood (P)

-2896.36 (0.0002)

-2708.10 (<0.0001)

AIC

5812.72

5452.20

BIC

5859.79

5536.02

Note. For AIC (Akaike information criterion) and Bayesian information criterion (BIC)
BIC the smaller the better.
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Physical summary scores were visually inspected using a scatter plot (Figure 5.2),
followed by including both linear and quadratic terms in the mixed model with results
presented in Table 5.4. The quadratic term for the model was not statistically significant
and thus removed from the model. The intercept, 51.8, describes the average physical
score at baseline; the years term describes the gradient or rate of growth in the unit of
years. On average, physical health summary scores increased by 0.3 units per year and
that change was statistically significant (p = 0.003). The average physical summary score
growth curve model for unadjusted physical scores over 8 years is shown in Figure 5.2.
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Figure 5.2: Scatter plot with connected lines and average physical health summary score
growth curve model for unadjusted psychosocial health scores over 8 years.
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Table 5.4: Growth curve models of physical summary scores across 8 years in those with
childhood-onset epilepsy

Variable

Unadjusted

Unadjusted

regression, with

regression, without

quadratic term for

quadratic term for

time

time

 (standard error) P

adjusted regression

 (SE) P

51.24 (0.64) <0.001

51.75 (0.57) <0.001

57.55 (3.84) <0.001

Years

1.06 (0.45) 0.019

0.28 (0.10) 0.003

0.27 (0.10) 0.004

Years2

-0.10 (0.05) 0.062

Intercept

Parental Depressive Score

-0.22 (0.06) 0.001

(CES-D)
Family Functioning (APGAR)

0.06 (0.17) 0.732

Family Resources (FIRM)

0.02 (0.06) 0.35
-4.66 (1.48) 0.002

Cognitive Problems
Variance (Intercept)

47.25 (7.63)

41.13 (0.19)

33.55 (5.22)

Variance (Years)

10.15 (3.86)

0.46 (0.19)

0.47 (0.19)

Variance (Years2)

0.11 (0.05)

Covariance (Intercept, Years)

-8.56 (4.33)

-1.63 (0.81)

-1.63 (0.76)

Covariance (Intercept, Years2)

0.77 (0.50)

Covariance (Years, Years2)

-1.02 (0.43)

Log restricted-likelihood (P)

-2821.45 (0.0071)

-2826.85 (0.0029)

-2793.96 (<0.0001)

AIC

5662.90

5665.70

5607.91

BIC

5709.95

5693.93

5654.91
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Presented here are the results for the second research question associated with Objective
2 (Which characteristics around the time of diagnosis with childhood-onset epilepsy are
associated with physical and psychosocial health summary subscale scores of HRQL
measurements eight years later?).
Parallel analyses were conducted for the CHQ psychosocial health and physical health
summary scales. Unadjusted associations between baseline risk factors and psychosocial
health scores 8 years post-diagnosis were assessed using Pearson correlations and
ANOVA (Table 5.5). Children who were older at the time of epilepsy onset (r = 0.18, p =
0.0210), had higher scores on psychosocial health (r = 0.53, p < 0.0001), family
functioning (APGAR; r = 0.33, p < 0.0001), and family resources (FIRM; r = 0.45, p <
0.0001), had no behavioural problems (F = 15.00, p = 0.0002), no cognitive problems (F
= 14.78, p = 0.0002), and families with a higher income (F = 1.91, p = 0.0487) had higher
psychosocial health scores 8 years later. In addition, children whose parents reported
higher scores on depressive symptoms (CES-D; r = -0.28, p = 0.0002) and family
demands (FILE; r = -0.33, p < 0.0001), had lower psychosocial health scores 8 years
later.
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Table 5.5: Associations between Baseline Risk Factors and 8-year CHQ Psychosocial
Health Scores
R

P-value

Child age

0.10

0.2045

Age at seizure onset

0.18

0.0210

Number of antiepileptic drugs

-0.07

0.3558

Health-related quality of life, CHQ-Psych

0.53

<0.0001

Epilepsy severity, GASE

0.12

0.1317

Parent age

-0.02

0.8458

Parent depressive symptoms, CES-D

-0.28

0.0002

Family functioning, APGAR

0.33

<0.0001

Family resources, FIRM

0.45

<0.0001

Family demands, FILE

-0.33

<0.0001

F (df)

P-value

Child gender

0.96 (1)

0.3294

Seizure type

0.89 (6)

0.5054

Behavior problems

15.00 (1)

0.0002

Cognitive problems

14.78 (1)

0.0002

Marital status

0.78 (4)

0.3783

Employment status

1.19 (4)

0.2763

Education

1.40 (5)

0.2272

Annual household income

1.91 (10)

0.0487
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Unadjusted associations between baseline risk factors and physical health scores 8 years
post-diagnosis were assessed using Pearson correlations and ANOVA (Table 5.6).
Children with higher physical scores (r = 0.31, p < 0.0001), family resources (FIRM; r =
0.19, p = 0.0132), and those without cognitive problems (F = 9.14, p = 0.0029) had
higher physical health scores 8 years later. In addition, children whose parents reported
having higher depressive symptoms scores at baseline (CES-D; r = -0.20, p = 0.0096) had
lower scores on physical health 8 years later.
Table 5.6: Associations between Baseline Risk Factors and 8-year CHQ Scores-Physical
Health
R

P-value

Child age

0.02

0.7952

Age at seizure onset

0.09

0.2723

Number of antiepileptic drugs

-0.01

0.9286

Health-related quality of life, CHQ-Physical

0.31

<0.0001

Epilepsy severity, GASE

0.09

0.2369

Parent age

-0.02

0.8134

Parent depressive symptoms, CES-D

-0.20

0.0096

Family functioning, APGAR

0.13

0.0857

Family resources, FIRM

0.19

0.0132

Family demands, FILE

-0.07

0.3926

F (df)

P-value

Child gender

0.34 (1)

0.5613

Seizure type

0.73 (6)

0.6292

Behavior problems

2.61 (1)

0.1081

Cognitive problems

9.14 (1)

0.0029

Marital status

0.78 (4)

0.3783

Employment status

1.19 (4)

0.2763

Education

0.64 (5)

0.6667

Annual household income

0.33 (10)

0.3331
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The results for the third research question associated with Objective 2 (What is the
average estimated course of HRQL from baseline to eight years later, while accounting
for associated baseline characteristics?) are presented here.
Below are results for psychosocial and physical health summary scores analyzed using
the mixed-effects models including baseline characteristics. Both linear and quadratic
terms for time were tested in each model.

5.3.1

Psychosocial Summary Score Results

All baseline characteristics found to be significant in the unadjusted analysis were
included in the adjusted model, to test the effect of time on psychosocial health summary
scores as a function of baseline characteristics. Any characteristic that was found to have
a p-value of less than 0.2 was recorded and added to the final model. The quadratic term
was statistically significant and remained in the model. The final model tested the effect
of time on psychosocial health scores as a function of child’s age at epilepsy onset, age at
onset of epilepsy, seizure severity (GASE), parent’s score on depressive symptoms (CESD), family functioning (APGAR), family resources (FIRM), family demands (FILE), and
child’s cognitive status.
The coefficient for time indicated that at time zero, if the slope of psychosocial health
scores were to remain unchanged, scores would linearly increase by an average of 1.4
points each year. However, as the quadratic term is significant and negative, the quadratic
term must be included in the interpretation, such that for each year increase, the slope
reduces by the coefficient for the quadratic term of time multiplied by two, or, 0.28 of a
psychosocial health unit. CHQ scores for psychosocial health appear to increase until 2
years post-diagnosis at which time HRQL remains stable until 8 years.
When entered into the final model, the coefficients for age at baseline, age at onset of
epilepsy, baseline severity of epilepsy, parental depressive symptoms, family functioning,
and family demands did not remain significant (Table 5.3). In other words, certain
baseline variables such as age at diagnosis and parental depressive scores are associated
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with final psychosocial health scores, but not over time. However, results indicate that
family resources at baseline did have a significant and positive association with
psychosocial health scores such that, for each family with a one-unit higher score in
family resources at baseline, psychosocial health scores increase by a factor of 0.3 per
unit of time (0.26, p = 0.002). Additionally, results indicate that presence of a cognitive
problems at baseline had a significant and negative association with psychosocial health
scores, such that if a child had cognitive problems at baseline, psychosocial health scores
would be lower, on average, by a factor of 6.8 compared to those without cognitive
problems. A graphical representation of the predicted growth curve across time is
presented in Figure 5.3.
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Figure 5.3: The average fitted growth curve model for adjusted psychosocial health
scores over 8 years.
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When examining information criteria, comparing the Level-1 unadjusted model and the
Level-2 adjusted model, both the Akaike information criterion (AIC) and the Bayesian
information criterion (BIC) decreased. The AIC and BIC for each model are presented in
Table 5.3.

5.3.2

Physical Summary Score Results

For the physical health summary score, the adjusted model examined the effect of
baseline characteristics on time trend of physical health summary scores. All baseline
characteristics found to be significant in the unadjusted analysis were tested in the model
independently. Any characteristic found to have a p-value of less than 0.2 was recorded
and added to the final model. The final model tested the effect of time on physical health
scores as a function of parent’s depressive symptoms score (CES-D), family functioning
(APGAR), family resources (FIRM), and child’s cognitive status.
When modelling time, the quadratic term was not statistically significant and was not
retained in the model. The coefficient for time was significant and positive, indicating
that, on average, physical health summary scores increased by 0.27 units per year (p =
0.004).
When entered in the final model, the coefficients for family functioning, and family
resources did not remain significant (Table 5.4). In other words, certain baseline variables
such as family functioning and resources are associated with 8-year physical scores, but
not over time. However, results indicate that parental depression scores at baseline did
have a significant, negative association with the physical summary score, such that as
parental depressive scores at baseline increase, physical health scores decrease by a factor
of 0.22 per unit of time (0.22, p = 0.001). Additionally, results indicate that presence of
cognitive problems at baseline had a significant, negative association with physical health
scores such that, if a child had cognitive problems at baseline, physical health scores
would be on average lower by a factor of 4.66 compared to those without cognitive
problems, while all other factors are held constant. A graphical representation of the
predicted growth curve across time is presented in Figure 5.4.
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Figure 5.4: The average fitted growth curve model for adjusted physical health summary
scores over 8 years.
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Fit statistics as quantified by the AIC and BIC were improved by the adjusted models.
Results in Table 5.4 showed that both AIC and BIC from adjusted model are smaller than
that from the unadjusted models.

5.4

Objective 3

To determine the change in HRQL over the 8 years following a diagnosis of childhoodonset epilepsy.

5.4.1

Proportion of Change Across Eight Years After Diagnosis

The results for the first research question associated with Objective 3 (For what
proportion of those with childhood-onset epilepsy does HRQL eight years after diagnosis
improve, worsen or not change from that reported around the time of diagnosis?) are
presented here.
The physical and psychosocial health summary scores derived from the CHQ were the
two outcome measures used in two parallel analyses. Change scores from baseline to 8
years were computed for both the psychosocial and the physical health summary scores.
As a minimal clinically important difference has not been established for the CHQ-PF50
to date, a change score greater than or equal to one half of a standard deviation of the
change score was used to represent a clinically important difference.
Using the CHQ-psychosocial health summary score and standard deviation method,
clinically important changes were calculated between baseline and 8 years later (Table
5.7). Based on one half of a standard deviation, a change in psychosocial health scores
larger or equal to 5.5 psychosocial health units was considered a clinically important
change. Across 8 years, 41% (95% CI: 22-48) of adolescents experienced a clinically
important improvement, whereas 59% experienced either no clinically important change
(37%, 95% CI: 30-45) or a clinically important decline (22%, 95% CI: 16-29).
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Table 5.7: Change in psychosocial health summary scores (CHQ) from baseline to 8
years after diagnosis of epilepsy (n = 158)
Number of

Proportion of

adolescents

adolescents (%)

Decrease

35

22.15

16.30-29.38

Increase

64

40.51

33.06-48.42

No Change

59

37.34

30.08-45.22

Type of change

CI (95%)

Using the CHQ-physical health summary score and standard deviation method, clinically
important changes were calculated between baseline and 8 years later (Table 5.8). Based
on one half of a standard deviation, a change in physical health scores larger or equal to
5.3 physical health units was considered a clinically important change. Across 8 years,
36% (95% CI: 29-44) of adolescents experienced a clinically important improvement
whereas 64% experienced either no clinically important change (54%, 95% CI: 46-61) or
a clinically important decline (11%, 95% CI: 7-17).
Table 5.8: Change in physical health summary scores (CHQ) from baseline to 8 years
after diagnosis of epilepsy (n = 158)
Number of

Proportion of

adolescents

adolescents (%)

Decrease

17

10.83

6.80-16.81

Increase

56

35.67

28.50-43.55

No Change

84

53.50

45.59-61.24

Type of change

59

CI (95%)

5.4.2

Proportion of Change Across Two to Eight Years After
Diagnosis

The results for the second question associated with Objective 3 (For what proportion of
those with childhood-onset epilepsy does HRQL eight years after diagnosis improve,
worsen or not change from that reported two years post-diagnosis?) are presented here.
The physical and psychosocial health summary scores derived from the CHQ were the
two outcome measures used in two parallel analyses. Change scores from 2-years to 8
years post-baseline were computed for both the psychosocial and the physical health
summary scores. A change score greater than or equal to one half of a standard deviation
of the change score was used to represent a clinically important difference.
Using the CHQ-psychosocial health summary score and standard deviation methods,
clinically important changes were calculated between 2 years and 8 years post-diagnosis
(Table 5.9). Based on one half of a standard deviation, a change in psychosocial health
scores larger or equal to 4.8 psychosocial health units was considered a clinically
important change. Across two to eight years post-diagnosis, 29% (95% CI: 22-36) of
adolescents experienced a clinically important improvement whereas 72% experienced
either no clinically important change (50%, 95% CI: 42-58) or a clinically important
decline (22%, 95% CI: 16-29).
Table 5.9: Change in psychosocial health summary scores (CHQ) from 2 years to 8 years
after diagnosis of epilepsy (n = 162)
Number of

Proportion of

adolescents

adolescents (%)

Decrease

35

21.60

15.88-28.69

Increase

46

28.40

21.92-35.90

No Change

81

50.00

42.28-57.71

Type of change

CI (95%)

Using the CHQ-physical health summary score and standard deviation methods,
clinically important changes were calculated between 2 years and 8 years post-diagnosis
(Table 5.10). Based on one half of a standard deviation, a change in physical health
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scores larger or equal to 4.4 physical health units was considered a clinically important
change. Across two to eight years post-diagnosis, 23% (95% CI: 17-30) of adolescents
experienced a clinically important improvement whereas, 77% experienced either no
clinically important change (58%, 95% CI: 50-65) or a clinically important decline (19%,
95% CI: 14-26).
Table 5.10: Change in physical summary scores (CHQ) from 2 years to 8 years after
diagnosis of epilepsy (n = 162)
Number of

Proportion of

adolescents

adolescents (%)

Decrease

31

19.25

13.83-26.16

Increase

37

22.98

17.07-30.19

No Change

93

57.76

49.92-65.23

Type of change

61

CI (95%)

Chapter 6

6

Discussion

This chapter discusses the findings of this thesis. The first section summarizes and
interprets the findings for each objective. The following sections, 6.2 and 6.3 describe the
strengths and limitations of the thesis. The next section provides recommendations for
future research. The final section presents conclusions and implications of this thesis.

6.1

Summary and Interpretation of Results

The purpose of this thesis was to describe the course of health-related quality of life
(HRQL) in those diagnosed with childhood-onset epilepsy, how HRQL in the long term
compares to levels in the general population, and what factors contribute to improvement,
decline or stability of long-term HRQL. The following summarizes and interprets the
findings for each research objective.

Objective 1
The purpose of Objective 1 was to evaluate the HRQL associated with childhood-onset
epilepsy eight years post-diagnosis. The parents of children with epilepsy included in our
sample reported their children were comparable to (or better than) their counterparts in
the general population on the majority of individual health concepts with no differences
in either of the two summary scores at 8 years post diagnosis. Parents of children with
epilepsy did report that their children were doing more poorly compared to the available
reports of parents of similarly-aged children from the general population on three health
concepts, one related to the child (role-emotional-behavioural), and two related to the
family (family limitations in activities, and parental impact-emotional). These findings
are of clinical relevance as they provide parents and clinicians with information regarding
long-term outcomes of children with epilepsy compared to their peers in the general
population.
Prior research comparing the HRQL of epilepsy cohorts to the general population has
suggested that HRQL in children with epilepsy is compromised compared to age-
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matched healthy children (Miller et al., 2003; Momeni et al., 2015; Taylor et al., 2011).
Compared with published normative data, children with epilepsy had poorer HRQL in
scales specifically related to child’s behaviour and the emotional well-being of parents
(Taylor et al., 2011). Momeni et al., (2015), provided additional support that the health
factor with the lowest score in their epilepsy sample was associated with the emotional
well-being of the parents. Prior research has not reported results on longer term HRQL in
adolescents with epilepsy compared to population counterparts. Previously, studies
reported cross-sectional results at a single time point, compared with sibling controls, or
did not focus on characteristics associated with HRQL (Baca et al., 2010; Connolly et al.,
2006; Sillanpää, Haataja, & Shinnar, 2004). The current study provides HRQL results
collected on the same cohort at multiple time points over the long term. Longitudinal
research prospectively measuring factors of HRQL are limited and often have relatively
short follow ups of less than three years (Austin et al., 2010; Modi, Ingerski, Rausch, &
Glauser, 2011). Similarly, the first phase of HERQULES compared the current cohort
with the general population up until two years post-diagnosis (Ferro et al., 2013;
Speechley et al., 2012), but left the question of longer-term comparison unanswered. The
current research extended the duration of follow up to eight years post-diagnosis, parents
of children with epilepsy reported poorer outcomes on the same three health factors, the
emotional and behavioural role on the child, family limitations in activities, and the
emotional impact of their child’s health on the parent, that were found to be poorer than
the normative population at the 2-year follow-up (Speechley et al., 2012). The results
from prior research, the first phase of HERQULES, and the present study are all
consistent that, on average, parents of children with epilepsy experience greater
emotional concern as a result of their child’s physical and/or psychosocial health,
compared to the population normative data.
The current results indicate that for our sample of children with epilepsy their parents
report them as having comparable or better HRQL at 8 years post diagnosis than parents
of those in the general population. Previous research has highlighted that parents of
children with newly diagnosed epilepsy often report improved HRQL despite often poor
seizure outcomes (Ferro, Camfield, et al., 2013). A potential explanation for why parents
in our epilepsy sample did not report worse outcomes than the general population on
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most of the HRQL individual domains or summary domain measurements may be the
notion of the disability paradox (Albrecht & Devlieger, 1999). The disability paradox is
defined as “the discrepancy between the objective limitations and suffering posed by
certain disabilities, and the reasonable or excellent quality of life reported by some
individuals living with them” (Carona, Pereira, Moreira, Silva, & Canavarro, 2013, p.
971). The paradox realizes that despite challenges associated with having a chronic
illness or disability, psychological growth and inner strength potentially contribute to a
balanced life perspective that in turn is reflected in positively reported HRQL (Albrecht
& Devlieger, 1999; Carona et al., 2013). For example, consider the individual aspect of
bodily pain; epilepsy is not characterized as a condition that is principally painful, a
parent may be carefully monitoring a child’s illness and they may rate their child’s bodily
pain incorporating a balance of other HRQL domains. The parent may consider a more
balanced life perspective and perceive aspects of HRQL as more positive in their children
compared to parents drawn from the general population. This perspective is supported in
the current research; parents of those with epilepsy in our sample reported that their
children experienced less pain or limitations due to pain after 8 years, compared to the
general population. This finding is consistent with prior research that found the Child
Health Questionnaire (CHQ) scale with the highest score among those newly diagnosed
with epilepsy was that of bodily pain (Momeni et al., 2015).
Another potential interpretation for parents in the epilepsy sample reporting better
outcomes than the general population on certain HRQL measurements over time may be
due to parents positively recalibrating their assessment of their child’s condition and
HRQL over time (Sajobi, Speechley, et al., 2017). This concept is called positive
response shift (Schwartz & Sprangers, 1999; Sprangers & Schwartz, 1999). At 8 years
after diagnosis our sample of children with epilepsy had similar reports of psychosocial
health compared to the general population. This was not the case at baseline or 2 years
after diagnosis, wherein, parents of children with epilepsy reported their children to have
poorer psychosocial health compared to the general population. A positive response shift
over time can suggest potential benefits such that the parent’s perception of the course of
their child’s HRQL is improving. For example, parents of children newly diagnosed with
epilepsy may initially rate their child’s HRQL as poor but then over time, they may adapt
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and develop positive mechanisms of dealing with their child’s circumstances and report
better HRQL. Research concluding that response shift should be considered as a
measurement bias has been contrasted by research highlighting a potential positive
outcome of a positive response shift and emphasizing the parent’s process adaptively
responding to a child’s diagnosis (Sajobi, Speechley, et al., 2017).
As the measure of HRQL analyzed here, the CHQ, is a generic measure, a reasonable
question to ask is whether our finding that levels of HRQL in our sample of children with
epilepsy were generally similar to their counterparts in the general population could be
attributable to the CHQ being incapable of capturing deficits in aspects of HRQL that
may be specific to epilepsy. We are reassured by other findings previously reported for
the HERQULES sample that this is not likely the case. Specifically, using a wellvalidated epilepsy- specific measure of HRQL, the Quality of Life in Childhood Epilepsy
Questionnaire (QOLCE), a similar pattern of findings resulted to those reported here; as
assessed by parents using the QOLCE, HRQL also improved in the first two years after
diagnosis and was sustained over the long term (Puka et al., 2020).
Of note, when validating the CHQ, data on children with epilepsy was collected to
provide a clinical benchmark (Landgraf et al., 1996). Including benchmarks in the
measure allowed for the questionnaire to compare their results from clinical samples to
their normative sample. The CHQ manual provides evidence that the scales in the CHQ
were able to discriminate between children with clinically defined conditions from a
representative U.S. sample and that differences observed in the average score between
groups exceeded measurement error (Landgraf et al., 1996).
Overall, results assessing HRQL using parent-report on the CHQ indicated that those
with childhood-onset epilepsy, have comparable or better HRQL 8 years post-diagnosis
than their counterparts in the general population. Overall, these results offer reassuring
information to parents with children newly diagnosed with epilepsy about the potential
for positive long-term outcomes. However, the results also point to the importance of
monitoring particular aspects of HRQL related to a child’s emotional and behavioural
problems limiting their everyday activities, their health interrupting family activities, and
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parents experiencing emotional worry as a result of their child’s health, to identify those
who could benefit from interventions targeted at improving any deficits observed.

Objective 2
The purpose of Objective 2 was to describe the course of HRQL over 8 years after
diagnosis of epilepsy. First, the unadjusted average estimated course of HRQL from
baseline to eight years later was described where both psychosocial and physical
summary scores changed significantly.
When the growth curve over time was modelled for psychosocial health, the quadratic
term of time was significant, suggesting that the score profile was not a simple linear one
but rather showed curvature. Specifically, the levels of psychosocial health increased
soon after diagnosis and then flattened after 2 years. As for physical health, there was a
linear improvement over time. In other words, over the duration of follow up physical
health scores increased.
The goal of the second and third questions associated with Objective 2 was to determine
which characteristics around the time of diagnosis were associated with HRQL measured
8 years later and to estimate the average course of HRQL from baseline to eight years
later while accounting for the identified, associated characteristics. Baseline
characteristics that predicted psychosocial health over 8 years were family resources and
presence of a cognitive problems in the child. Baseline characteristics that predicted
physical health over 8 years were parental depressive scores and presence of cognitive
problems in the child. Both psychosocial and physical health growth curves followed the
same growth pattern suggested in the unadjusted analysis. In summary, a child having
cognitive problems predicted both psychosocial and physical health over time; family
resources predicted psychosocial health and parental depression predicted physical
health.
Parental depressive symptoms and family factors have been found to contribute to HRQL
in children with epilepsy (Connolly et al., 2006; Jain et al., 2018; Puka et al., 2019). Over
two years, family environment was found to be associated with HRQL and play a
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substantial role in children’s HRQL (Speechley et al., 2012; Ferro, Camfield, et al.,
2013). The current research extends past the 2-year follow up and provides a longer-term
analysis of family factors that are related to HRQL over time. Consistent with our
findings, a recent analysis of the HERQULES cohort across ten years supports that better
family environment at the time of diagnosis is associated with better HRQL over the
long-term (Puka et al., 2020).
Comorbid conditions among children with epilepsy are common (Pastor et al., 2015;
Sillanpää & Cross, 2009). In the current research, having cognitive problems predicted
both psychosocial and physical health over time. Reflecting on prior research, the
presence of cognitive problems was associated with HRQL two years after diagnosis in
the same cohort (Speechley et al., 2012). Moreover, problems associated with child
behaviour and cognition were the strongest predictors of HRQL over 2 years postdiagnosis (Ferro, Camfield, et al., 2013). The current findings are also consistent with
previously reported results from the HERQULES sample, using a disease-specific
measure of HRQL, indicating that absence of comorbidities, such as cognitive problems
at the time of diagnosis are associated with better HRQL over 10 years post diagnosis
(Puka et al., 2020). The similarity in findings when using a generic and a disease-specific
measure, both in the short- and long-term follow-up within this sample strengthens the
suggestion that those baseline factors highlighted as potential targets for intervention
given the persistence of association with HRQL over the long-term.
The presence of cognitive problems has been considered one of the strongest predictors
of HRQL (Ferro et al., 2013; Puka et al., 2020; Speechley et al., 2012). Notably, Conway
et al. (2016), emphasized the importance of both child cognition and family variables in
the HRQL of children with epilepsy. Cognitive problems are not always considered
modifiable; however, parent and family environment has been emphasized as a potential
target for patient care and early intervention. Research has shown that parent and family
environment has a great impact on a child’s HRQL (Rodenburg, Meijer, Deković, &
Aldenkamp, 2005). Research highlighting comprehensive care and interventions targeting
potentially modifiable factors alongside medical interventions has been suggested to
improve HRQL (Loiselle, Ramsey, Rausch, & Modi, 2016). Risk factors that have been
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identified as modifiable and lead to improvement of unfavorable trajectories include
those related to family environment and parental depressive symptoms. Moving towards
family centered care can serve to intervene on risk factors that are amenable to change
and improve HRQL trajectories (Ferro, Camfield, et al., 2013). In addition to providing
targeted and comprehensive care, the timing for initiation of care is important. Research
stresses the importance of identifying those at risk for reduced quality of life at the time
of diagnosis, so that early intervention can begin (Taylor et al., 2011). The current
research adds evidence that the changes in HRQL that occur during the first 2 years after
diagnoses continue over the long term, and that targeting risk factors near the time of
diagnosis may be important in identifying children at risk for poor HRQL and potentially
improving HRQL over the long term.

Objective 3
The goal of Objective 3 was to determine the change in HRQL between time of diagnosis
and 8 years later. This objective was split between assessing the change in HRQL,
psychosocial and physical health separately, at time of diagnosis to 8-years later and
additionally between 2 years later and 8 years later.
The interest in comparing baseline to 8 years and 2 years to 8 years stems from prior
literature on the change in HRQL from baseline to 2 years. A prior study, Speechley et al
(2012), assessed clinically important changes in both psychosocial and physical health
scores over 2-years in children newly diagnosed with epilepsy.
The first question of Objective 3 assessed the proportion of those with childhood-onset
epilepsy for which HRQL improved, worsened or stayed the same across 8 years. When
assessing psychosocial health, just over 40% of participants experienced a clinically
important improvement across 8 years. For physical health, more than one third of
participants experienced a clinically important improvement.
The second question of Objective 3 assessed the proportion of those with childhood-onset
epilepsy for whom HRQL improved, worsened, or stayed the same across the period of 2
years after diagnosis to 8 years after diagnosis. For psychosocial health, just under one
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third of participants experienced a clinically important improvement. For physical health,
just under one quarter experienced a clinically important improvement.
The study found that 28% of individuals experienced a clinically important improvement
in psychosocial health and 23% of individuals experienced a clinically important
improvement in physical health between the second and eight year after diagnosis. The
comparison between the proportion who improved from baseline to 2 years and those that
improved across the 8-year follow up is similar. A possible explanation may include that
those who improved from baseline to 2 years may be closer to the high range of the CHQ
and may have less room for further growth, resulting in ceiling effects. Additionally, the
sample retained at 8-year follow up may have been more likely to represent a subsample
of the initial cohort that fared better than those who were lost to follow up, thus resulting
in similar findings over the full 8 years as between baseline and 2 years.
The proportion of youth who improved, worsened or remained stable over different
periods of time may assist clinicians in discussing with families what is known about
children with epilepsy, in terms of what can be reasonably expected regarding the course
of HRQL over the years after diagnosis.
It is important to explore the effect of attrition when interpreting these results. Of the
original sample, parents of 43% who were 18 years old or younger were retained to the 8year follow-up. When comparing baseline characteristics, compared to parents who
began the study but were lost to follow-up before the 8-year follow-up, there were no
baseline differences in terms of the child’s diagnosed epilepsy syndrome, number of
AEDs taken, frequency of seizures, severity of epilepsy, or whether the child had
behavioural problems or on the age, employment, or marital status of parents. However,
parents who completed all five questionnaires, had more education, higher household
income, fewer depression symptoms, better family functioning, better family resources,
fewer family demands and their children were older and less likely to have cognitive
problems than other lost to follow-up. In interpreting the current findings, we do need to
consider that those families that were more advantaged, based on sociodemographic
factors, may have been more likely to stay in the study. In that case, the effect of attrition
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bias in our sample may have resulted in an under-estimation of compromised HRQL and
the proportion of those with clinically important improvements in HRQL we report may
be larger in our study sample than if the entire baseline sample had been retained.

6.2

Strengths of the Current Research

One of the strengths of this research is the study design. HERQULES was a large, multicenter, prospective cohort study that recruited incident cases from across Canada with a
diverse range in the type of epilepsy diagnosed. HERQULES was long term and followed
a group of individuals from childhood, into adolescence and adulthood. This is the first
study of its kind that not only measured relevant clinical variables but also the family
environment in an assessment of the HRQL of children and their parents up to 10 years
after the diagnosis of epilepsy.
Additionally, the measures used in the study were reliable and well validated and
included both epilepsy-specific and generic measures of HRQL. Particularly the use of a
robust generic measure, the CHQ, allowed for comparison with the general population
throughout the duration of the 8-year follow up.
Methodologically, the use of a mixed effects methods strengthens the current study.
Mixed effects models manage serial growth data, allowing the flexibility to
simultaneously predict individual curves, model the average course and incorporate
baseline variables into the model (Johnson, Balakrishna, & Griffiths, 2013). Furthermore,
mixed effects models allow for heterogeneity among subjects in their trajectories of
change and account for missing data (Singer & Willett, 2003).
Additionally, the study presents both research and clinically relevant data, growth
modelling and proportions of change, respectively. Therefore, results can be used to
influence future research as well as present information to clinicians working with
children newly diagnosed with epilepsy.
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6.3

Limitations of the Current Research

Although access to data from a long-term prospective study presented a unique
opportunity, the current study has some limitations. First, as expected with the long-term
follow-up of any cohort, there was attrition. The effect of attrition bias indicated a
retention of families that tend to be more advantaged, which may mean that the sample
on which the results are based is biased toward those likely to have more positive
outcomes such as better HRQL. Thus, leading to an over-estimation of the long-term
level of HRQL for those with childhood-onset epilepsy.
Another potential weakness is that patients were recruited from pediatric neurology
practices across Canada. This may have resulted in a sample not fully representative of
children newly diagnosed with epilepsy in Canada. This concern is somewhat mitigated,
however, by the finding that family physicians refer over 80% of children diagnosed with
epilepsy to a pediatric neurologist (Speechley, Levin, Wiebe, & Blume, 1999).
Additionally, at the final follow-up, the majority of youth in this study were seizure free
for over five years which is in accordance of reported the reported course of epilepsy into
adulthood (Sillanpää & Schmidt, 2017).
It should also be noted that data analysed here were based on parent or physician report.
In the final two follow-ups of HERQULES, self-report data were collected from the
youth with epilepsy. It is generally agreed that it is important, whenever possible, to
solicit both parent and child report of children’s HRQL. Differences do exist between
child and parent report of HRQL and it is important to understand both perspectives
(Baca et al., 2010; Speyer, Herbinet, Vuillemin, Chastagner, & Briancon, 2009;
Sundaram, Landgraf, Neighbors, Cohn, & Alonso, 2007) . It is the case, however, that
young children are not always able to self-report on their HRQL due to lack of
developmental maturity or illness (Puka et al., 2020). For the purposes of assessing the
course of HRQL over the course of childhood and adolescence and incorporating parental
and family measures, use of parent report at all time points provides consistency in the
reporter that is essential for repeated measures (Fong et al., 2018; Matsumoto, Vitale,
Hyman, & Roye, 2011). As the aim of the current study was to assess the course of
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HRQL in children as young as four years of age at diagnosis of epilepsy across time, a
parent report measure was required to provide a consistent proxy reporter.
Finally, as a Canadian normative population for the CHQ was not available, data from a
U.S. normative sample was used to compare to our sample. Other researchers have
compared Canadian data with U.S. norms as well as Australian norms (Klassen et al.,
2004). In an ADHD study, U.S. and Australian norms did not significantly differ from
one another (Klassen et al., 2004). The previous report from the HERQULES cohort used
the published U.S. norms from the CHQ as the comparison (Speechley et al., 2012) and
thus use of the same normative population provides consistency and ease of comparison
between reports.

6.4

Recommendations for Future Research

Future research should focus on evaluating self-reported HRQL prospectively over the
long term. Evaluating self-report measures will provide an understanding of how the
individual diagnosed with epilepsy perceives their own HRQL over time. The current
results are novel in that they provide a longer-term picture of HRQL that improves over
the first two years and is sustained over the long term in those diagnosed with childhood
onset epilepsy. Additionally, family environment and presence of cognitive problems was
associated with HRQL over 2 years continues to predict HRQL in the long term.
Understanding that there is a potential need to identify those at risk for compromised
HRQL early after diagnosis presents the opportunity to target interventions that address
modifiable factors, such as those associated with the family environment. Evaluating a
family-centered approach may be such a recommendation.

6.5

Conclusions and Implications

In conclusion, after 8 years, HRQL in the epilepsy sample was the same or better on
average compared to the normative population. However, almost a quarter are
experiencing worse HRQL than baseline over the 8-year period and over a third
experienced no clinically important change. Additionally, family resources, parental
depressive symptoms, and cognitive comorbidities are associated with physical and
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psychosocial health growth over time. Taken together, the long-term prognosis of
childhood epilepsy is good; however, there is a subsample of youth who are at risk for
compromises in long-term HRQL. The current research extends the follow up of
HERQULES from 2 to 8 years and provides a more complete picture of HRQL for those
newly diagnosed with epilepsy. For the first time, children newly diagnosed with epilepsy
are compared to the general population across multiple time points over 8 years. The
current results are important in ascertaining additional variables over and above seizure
experience to identify those at risk for poor HRQL over the long term that may
potentially benefit from early interventions targeting the child and their family unit.
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